WO2005006939A2 - Method and apparatus for body fluid sampling and analyte sensing - Google Patents

Method and apparatus for body fluid sampling and analyte sensing Download PDF

Info

Publication number
WO2005006939A2
WO2005006939A2 PCT/US2004/019125 US2004019125W WO2005006939A2 WO 2005006939 A2 WO2005006939 A2 WO 2005006939A2 US 2004019125 W US2004019125 W US 2004019125W WO 2005006939 A2 WO2005006939 A2 WO 2005006939A2
Authority
WO
WIPO (PCT)
Prior art keywords
penetrating member
cartridge
penetrating
ofthe
device
Prior art date
Application number
PCT/US2004/019125
Other languages
French (fr)
Other versions
WO2005006939A3 (en
Inventor
Barry Dean Briggs
Tom Shulte
Don Alden
James Ross
Ganapati Mauze
Dominique M. Freeman
Original Assignee
Pelikan Technologies, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US47804103P priority Critical
Priority to US60/478,041 priority
Priority to US60/478,662 priority
Priority to US47866203P priority
Priority to US47869203P priority
Priority to US60/478,692 priority
Priority to US48332403P priority
Priority to US60/483,324 priority
Application filed by Pelikan Technologies, Inc. filed Critical Pelikan Technologies, Inc.
Publication of WO2005006939A2 publication Critical patent/WO2005006939A2/en
Publication of WO2005006939A3 publication Critical patent/WO2005006939A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/157Devices characterised by integrated means for measuring characteristics of blood
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150015Source of blood
    • A61B5/150022Source of blood for capillary blood or interstitial fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150053Details for enhanced collection of blood or interstitial fluid at the sample site, e.g. by applying compression, heat, vibration, ultrasound, suction or vacuum to tissue; for reduction of pain or discomfort; Skin piercing elements, e.g. blades, needles, lancets or canulas, with adjustable piercing speed
    • A61B5/150106Means for reducing pain or discomfort applied before puncturing; desensitising the skin at the location where body is to be pierced
    • A61B5/150152Means for reducing pain or discomfort applied before puncturing; desensitising the skin at the location where body is to be pierced by an adequate mechanical impact on the puncturing location
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150053Details for enhanced collection of blood or interstitial fluid at the sample site, e.g. by applying compression, heat, vibration, ultrasound, suction or vacuum to tissue; for reduction of pain or discomfort; Skin piercing elements, e.g. blades, needles, lancets or canulas, with adjustable piercing speed
    • A61B5/150167Adjustable piercing speed of skin piercing element, e.g. blade, needle, lancet or canula, for example with varying spring force or pneumatic drive
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150175Adjustment of penetration depth
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150358Strips for collecting blood, e.g. absorbent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150374Details of piercing elements or protective means for preventing accidental injuries by such piercing elements
    • A61B5/150381Design of piercing elements
    • A61B5/150412Pointed piercing elements, e.g. needles, lancets for piercing the skin
    • A61B5/150427Specific tip design, e.g. for improved penetration characteristics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150374Details of piercing elements or protective means for preventing accidental injuries by such piercing elements
    • A61B5/150381Design of piercing elements
    • A61B5/150503Single-ended needles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150374Details of piercing elements or protective means for preventing accidental injuries by such piercing elements
    • A61B5/150534Design of protective means for piercing elements for preventing accidental needle sticks, e.g. shields, caps, protectors, axially extensible sleeves, pivotable protective sleeves
    • A61B5/150572Pierceable protectors, e.g. shields, caps, sleeves or films, e.g. for hygienic purposes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150763Details with identification means
    • A61B5/150786Optical identification systems, e.g. bar codes, colour codes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150801Means for facilitating use, e.g. by people with impaired vision; means for indicating when used correctly or incorrectly; means for alarming
    • A61B5/150824Means for facilitating use, e.g. by people with impaired vision; means for indicating when used correctly or incorrectly; means for alarming by visual feedback
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/151Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
    • A61B5/15101Details
    • A61B5/15103Piercing procedure
    • A61B5/15107Piercing being assisted by a triggering mechanism
    • A61B5/15113Manually triggered, i.e. the triggering requires a deliberate action by the user such as pressing a drive button
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/151Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
    • A61B5/15101Details
    • A61B5/15115Driving means for propelling the piercing element to pierce the skin, e.g. comprising mechanisms based on shape memory alloys, magnetism, solenoids, piezoelectric effect, biased elements, resilient elements, vacuum or compressed fluids
    • A61B5/15117Driving means for propelling the piercing element to pierce the skin, e.g. comprising mechanisms based on shape memory alloys, magnetism, solenoids, piezoelectric effect, biased elements, resilient elements, vacuum or compressed fluids comprising biased elements, resilient elements or a spring, e.g. a helical spring, leaf spring, or elastic strap
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/151Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
    • A61B5/15101Details
    • A61B5/15115Driving means for propelling the piercing element to pierce the skin, e.g. comprising mechanisms based on shape memory alloys, magnetism, solenoids, piezoelectric effect, biased elements, resilient elements, vacuum or compressed fluids
    • A61B5/15123Driving means for propelling the piercing element to pierce the skin, e.g. comprising mechanisms based on shape memory alloys, magnetism, solenoids, piezoelectric effect, biased elements, resilient elements, vacuum or compressed fluids comprising magnets or solenoids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/151Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
    • A61B5/15101Details
    • A61B5/15126Means for controlling the lancing movement, e.g. 2D- or 3D-shaped elements, tooth-shaped elements or sliding guides
    • A61B5/15128Means for controlling the lancing movement, e.g. 2D- or 3D-shaped elements, tooth-shaped elements or sliding guides comprising 2D- or 3D-shaped elements, e.g. cams, curved guide rails or threads
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/151Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
    • A61B5/15101Details
    • A61B5/15126Means for controlling the lancing movement, e.g. 2D- or 3D-shaped elements, tooth-shaped elements or sliding guides
    • A61B5/15132Means for controlling the lancing movement, e.g. 2D- or 3D-shaped elements, tooth-shaped elements or sliding guides comprising tooth-shaped elements, e.g. toothed wheel or rack and pinion
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/151Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
    • A61B5/15146Devices loaded with multiple lancets simultaneously, e.g. for serial firing without reloading, for example by use of stocking means.
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/151Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
    • A61B5/15146Devices loaded with multiple lancets simultaneously, e.g. for serial firing without reloading, for example by use of stocking means.
    • A61B5/15148Constructional features of stocking means, e.g. strip, roll, disc, cartridge, belt or tube
    • A61B5/15149Arrangement of piercing elements relative to each other
    • A61B5/15151Each piercing element being stocked in a separate isolated compartment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/151Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
    • A61B5/15146Devices loaded with multiple lancets simultaneously, e.g. for serial firing without reloading, for example by use of stocking means.
    • A61B5/15148Constructional features of stocking means, e.g. strip, roll, disc, cartridge, belt or tube
    • A61B5/15157Geometry of stocking means or arrangement of piercing elements therein
    • A61B5/15159Piercing elements stocked in or on a disc
    • A61B5/15161Characterized by propelling the piercing element in a radial direction relative to the disc
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/151Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
    • A61B5/15146Devices loaded with multiple lancets simultaneously, e.g. for serial firing without reloading, for example by use of stocking means.
    • A61B5/15148Constructional features of stocking means, e.g. strip, roll, disc, cartridge, belt or tube
    • A61B5/15157Geometry of stocking means or arrangement of piercing elements therein
    • A61B5/15159Piercing elements stocked in or on a disc
    • A61B5/15163Characterized by propelling the piercing element in an axial direction relative to the disc
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/151Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
    • A61B5/15146Devices loaded with multiple lancets simultaneously, e.g. for serial firing without reloading, for example by use of stocking means.
    • A61B5/15148Constructional features of stocking means, e.g. strip, roll, disc, cartridge, belt or tube
    • A61B5/15176Stocking means comprising cap, cover, sheath or protection for aseptic stocking
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/151Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
    • A61B5/15146Devices loaded with multiple lancets simultaneously, e.g. for serial firing without reloading, for example by use of stocking means.
    • A61B5/15182Means for keeping track or checking of the total number of piercing elements already used or the number of piercing elements still remaining in the stocking, e.g. by check window, counter, display
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/151Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
    • A61B5/15186Devices loaded with a single lancet, i.e. a single lancet with or without a casing is loaded into a reusable drive device and then discarded after use; drive devices reloadable for multiple use
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/32Surgical cutting instruments
    • A61B17/3209Incision instruments
    • A61B17/32093Incision instruments for skin incisions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14532Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150206Construction or design features not otherwise provided for; manufacturing or production; packages; sterilisation of piercing element, piercing device or sampling device
    • A61B5/150274Manufacture or production processes or steps for blood sampling devices

Abstract

The method comprises providing a lancing device comprising a penetrating member (68) driver having a position sensor (74) and a processor (60) that can determine the relative position and velocity of the penetrating member (18,72) based on measuring relative position of the penetrating member with respect to time; providing a predetermined velocity control trajectory based on a model of the driver (68) and a model of tissue to be contacted. Furthermore, a feedforward control is able to maintain penetrating member velocity along the trajectory.

Description

METHOD AND APPARATUS FOR BODY FLUID SAMPLING AND ANALYTE SENSING

BACKGROUND OF THE INVENTION Lancing devices are known in the medical health-care products industry for piercing the skin to produce blood for analysis. Typically, a drop of blood for this type of analysis is obtained by making a small incision in the fingertip, creating a small wound, which generates a small blood droplet on the surface ofthe skin. Early methods of lancing included piercing or slicing the skin with a needle or razor. Current methods utilize lancing devices that contain a multitude of spring, cam and mass actuators to drive the lancet. These include cantilever springs, diaphragms, coil springs, as well as gravity plumbs used to drive the lancet. The device may be held against the skin and mechanically triggered to ballistically launch the lancet.

Unfortunately, the pain associated with each lancing event using known technology discourages patients from testing. In addition to vibratory stimulation ofthe skin as the driver impacts the end of a launcher stop, known spring based devices have the possibility of firing lancets that harmonically oscillate against the patient tissue, causing multiple strikes due to recoil. This recoil and multiple strikes ofthe lancet is one major impediment to patient compliance with a structured glucose monitoring regime. Another impediment to patient compliance is the lack of spontaneous blood flow generated by known lancing technology. In addition to the pain as discussed above, a patient may need more than one lancing event to obtain a blood sample since spontaneous blood generation is unreliable using known lancing technology. Thus the pain is multiplied by the number of attempts required by a patient to successfully generate spontaneous blood flow. Different skin thickness may yield different results in terms of pain perception, blood yield and success rate of obtaining blood between different users ofthe lancing device. Known devices poorly account for these skin thickness variations. Variations in skin thickness including the stratum corneum and hydration ofthe epidermis can yield different results between different users. Spontaneous blood droplet generation is dependent on reaching the blood capillaries and venuoles, which yield the blood sample. It is therefore an issue of correct depth of penetration ofthe cutting device. Due to variations in skin thickness and hydration, some types of skin will deform more I i before cutting starts, and hence the actual depth of penetration will be less, resulting in less capillaries and venuoles cut and less spontaneous blood generation. Known lancing devices fail to provide accurate sensing of lancet position. Thus they do not know exactly how far the penetrating member has cut into the tissue. This lack of position sensing is one reason for more painful lancing associated with known fluid sampling devices. Additionally, known lancing devices fail to have sufficiently accurate control of lancet position and velocity to achieve a spontaneous blood generation in a relatively pain free manner.

SUMMARY OF THE INVENTION The present invention provides solutions for at least some ofthe drawbacks discussed above. The technical field relates to the lancing ofthe finger to obtain a body fluid or blood sample for the analysis of that sample. Because the penetration distance is a strong predictor ofthe success ofthe lancing event for spontaneous blood generation, the ability ofthe device to accurately control this distance is of interest. Specifically, some embodiments ofthe present invention provide an improved body fluid sampling device. For some embodiments of penetrating member drivers, the invention provides improved methods for controlling the velocity and cutting efficient of a penetrating member. At least some of these and other objectives described herein will be met by embodiments ofthe present invention. In one aspect, the present invention provides improved lancing devices operating with adaptive control algorithms. Because ofthe very high speeds that embodiments of the present invention may move their penetrating members, feedback control may not be sufficient, due to the short amount of time available. In one embodiment, the present invention provides desired parameters, based on the models ofthe penetrating member, the penetrating member driver, and the targeted tissue. Based on this model, the system may have predictive information stored in lookup tables on how to drive the penetrating member driver and when to apply braking force so that the device performs as desired to arrive at a desired depth and to provide a desired level of cutting efficiency and/or performance. In one embodiment, a method of controlling a penetrating member is provided. The method comprises providing a lancing device having a penetrating member driver with a position sensor and a processor that can determine the relative position and velocity ofthe penetrating member based on measuring relative position ofthe penetrating member with respect to time; providing a look up table having desired velocity trajectory based on empirical data; and using control to adjust lancet velocity to maintain penetrating member velocity along said trajectory. In another embodiment, the present invention relates to the way that an electronically driven lancing device controls the trajectory ofthe inbound lancet up to the point of maximum extension or penetration into a target tissue. This is the point of maximum penetration ofthe lancet into the skin. This embodiment ofthe present invention comprises a control algorithm, that when combined with the necessary hardware to execute the control instructions, increases the depth accuracy ofthe penetrating member. The present invention also provides improved cutting efficiency by providing lancet behavior that is optimized for cutting tissue. In one aspect, the present invention involves learning tlirough testing what the ideal setup parameters are and then using more complicated feedback systems to get results similar to a feed-forward system. In other aspects, the present invention may involve manual braking, braking with zero residual energy, braking only, preserving acceleration, and appropriate force for smart braking. The system may further comprise means for coupling the force generator with one ofthe penetrating members. The system may further comprise a penetrating member sensor positioned to monitor a penetrating member coupled to the force generator, the penetrating member sensor configured to provide information relative to a depth of penetration of a penetrating member through a skin surface. The depth of penetration may be about 100 to 2500 microns. The depth of penetration may be about 500 to 750 microns. The depth of penetration may be, in this nonlimiting example, no more than about 1000 microns beyond a stratum corneum thickness of a skin surface. The depth of penetration may be no more than about 500 microns beyond a stratum corneum thickness of a skin surface. |i The depth of penetration may be no more than about 300 microns beyond a stratum corneum thickness of a skin surface. The depth of penetration may be less than a sum of a stratum corneum thickness of a skin surface and 400 microns. The penetrating member sensor may be further configured to control velocity of a penetrating member. The active penetrating member may move along a substantially linear path into the tissue. ι The active penetrating member may move along an at least partially curved path into the tissue. The driver may be a voice coil drive force generator. The driver may be a rotary voice coil drive force generator. The penetrating member sensor may be coupled to a processor with control instructions for the penetrating member driver. ,' The processor may include a memory for storage and retrieval of a set of penetrating member profiles utilized with the penetrating member driver. The processor may be utilized to monitor position and speed of a penetrating member as the penetrating member moves in a first direction. The processor may be utilized to adjust an application of force to a penetrating member to achieve a desired speed ofthe penetrating member. The processor may be utilized to adjust an application offeree to a penetrating member when the penetrating member contacts a target tissue so that the penetrating member penetrates the target tissue within a desired range of speed. The processor may be utilized to monitor position and speed of a penetrating member as the penetrating member moves in the first direction toward a target tissue, wherein the application of a launching force to the penetrating member is controlled based on position and speed ofthe penetrating member. The processor may be utilized to control a withdraw force to the penetrating member so that the penetrating member moves in a second direction away from the target tissue. In the first direction, the penetrating member may move toward the target tissue at a speed that is different than a speed at which the penetrating member moves away from the target tissue. In the first direction the penetrating member may move toward the target tissue at a speed that is greater than a speed at which the penetrating member moves away from the target tissue. The speed of a penetrating member in the first direction may be the range of about

2.0 to l0.0 m/sec. The average velocity ofthe penetrating member during a tissue penetration stroke in the first direction may be about 100 to about 1000 times greater than the average velocity ofthe penetrating member during a withdrawal stroke in a second direction. A further understanding ofthe nature and advantages ofthe invention will become apparent by reference to the remaining portions ofthe specification and drawings.

BRIEF DESCRIPTION OF THE DRAWINGS Figure 1 illustrates an embodiment of a controllable force driver in the form of a cylindrical electric penetrating member driver using a coiled solenoid -type configuration. Figure 2A illustrates a displacement over time profile of a penetrating member driven by a harmonic spring/mass system. Figure 2B illustrates the velocity over time profile of a penetrating member driver by a harmonic spring/mass system. Figure 2C illustrates a displacement over time profile of an embodiment of a controllable force driver. Figure 2D illustrates a velocity over time profile of an embodiment of a controllable force driver. Figure 3 is a diagrammatic view illustrating a controlled feed-back loop. Figure 4 is a perspective view of a tissue penetration device having features ofthe invention. Figure 5 is an elevation view in partial longitudinal section ofthe tissue penetration device of Figure 4. Figure 6 shows a cutaway perspective view of one embodiment ofthe device according to the present invention. n Figure 7 shows an exploded perspective view of one embodiment ofthe present invention. Figures, 8 and 9 show top and bottom views of one embodiment of a chassis for use with the present invention. Figures 10 to 14 show various views of a cartridge according to the present invention. Figure 15 shows one embodiment of cartridge with one embodiment of a seal and an analyte detecting member layer. > Figure 16 shows one embodiment ofthe analyte detecting member layer. Figures 17-21 show still further embodiments of a cartridge according to the present invention. Figure 22-29 show other embodiments of housing multiple penetrating members. Figures 30 and 31 show a simplified launcher for use with a cartridge. Figures 32-37 show still further embodiments of a cartridge according to the present invention. Figures 38-39 show embodiments of a clutch for engaging a penetrating member. Figures 40-42 show a device for loading a plurality of penetrating members. Figures 43-52 show embodiments for engaging penetrating members. Figures 53-58 show various configurations for housing a plurality of penetrating members. Figures 59-82 show still further embodiments for housing a plurality of penetrating members. Figures 83-87 show various perspective views of one embodiment of a device for breaking a seal and rotating the cartridge. Figures 88 to 91 show views of a cam and cam follower for controlling motion of a punch device. Figures 92-93 show still further embodiments of a device according to the present invention. Figures 94-99 show perspective views of a housing according to the present invention. Figures 100-101 show a schematic of a device according to the present invention.- Figures 102-103 show perspective views of a housing according to the present invention. Figure 104 shows a schematic of a device according to the present invention. - Figure 105 shows a close-up view of a cartridge according to the present invention. Figure 106 shows a close up of a punch according to the present invention. Figure 107 shows one embodiment of disc for use with the present invention. Figure 108 shows one view ofthe disc in a penetrating member device. Figure 109 shows another embodiment of a device that may use a disc as described in Figure 107. Figure 110 shows a cutaway perspective view of a device housing a cartridge according to the present invention. Figures 111-113 shows perspective views of interior elements for indexing a cartridge according to the present invention. Figure 114 shows elements for indexing a cartridge. DESCRIPTION OF THE SPECIFIC EMBODIMENTS The present invention provides a multiple analyte detecting member solution for body fluid sampling. Specifically, some embodiments ofthe present invention provides a multiple analyte detecting member and multiple penetrating member solution to measuring analyte levels in the body. The invention may use a high density design. It may use penetrating members of smaller size, such as but not limited to diameter or length, than known lancets. The device may be used for multiple lancing events without having to remove a disposable from the device. The invention may provide improved sensing capabilities. At least some of these and other objectives described herein will be met by embodiments ofthe present invention. It is to be understood that both the foregoing general description and the following detailed description are exemplary and explanatory only and are not restrictive ofthe invention, as claimed. It must be noted that, as used in the specification and the appended I ' " ' I claims, the singular forms "a", "an" and "the" include plural referents unless the context

Figure imgf000009_0001
to the extent that they conflict with teachings explicitly set forth in this specification. In this specification and in the claims which follow, reference will be made to a number of terms which shall be defined to have the following meanings: "Optional" or "optionally" means that the subsequently described circumstance may or may not occur, so that the description includes instances where the circumstance occurs and instances where it does not. For example, if a device optionally contains a feature for analyzing a blood sample, this means that the analysis feature may or may not be present, and, thus, the description includes structureis wherein a device possesses the analysis feature and structures wherein the analysis feature is not present. The present invention may be used with a variety of different penetrating member drivers. It is contemplated that these penetrating member drivers may be spring based, solenoid based, magnetic driver based, nanomuscle based, or based on any other mechanism useful in moving a penetrating member along a path into/tissue. It should be noted that the present invention is not limited by the type of driver used with the penetrating member feed mechanism. One suitable penetrating member driver for use with the present invention is shown in Figure 1. This is an embodiment of a solenoid type electromagnetic driver that is capable of driving an iron core or slug mounted to the penetrating member assembly using a direct current (DC) power supply. The electromagnetic driver includes a driver coil pack that is divided into three separate coils along the path ofthe penetrating member, two end coils and a middle coil. Direct current is alternated to the coils to advance and retract the penetrating member. Although the driver coil pack is shown with three coils, any suitable number of coils may be used, for example, 4, 5, 6, 7 or more coils may be used. The present invention may be used with a variety of different penetrating member drivers. It is contemplated that these penetrating member drivers may be spring based, solenoid based, magnetic driver based, nanomuscle based, or based on any other mechanism useful in moving a penetrating member along a path into tissue. It should be noted that the present invention is not limited by the type of driver used with the penetrating member feed mechanism. One suitable penetrating member driver for use with the present invention is shown in Figure 1. This is an embodiment of a solenoid type electromagnetic driver that is capable of driving an iron core or slug mounted to the penetrating member assembly using a direct current (DC) power supply. The electromagnetic driver includes a driver coil pack that is divided into three separate coils along the path ofthe penetrating member, two end coils and a middle coil. Direct current is alternated to the coils to advance and retract the penetrating member. Although the driver coil pack is shown with three coils, any suitable number of coils may be used, for example, 4, 5, 6, 7 or more coils may be used. Referring to the embodiment of Figure 1, the stationary iron housing 10 may contain the driver coil pack with a first coil 12 flanked by iron spacers 14 which concentrate the magnetic flux at the inner diameter creating magnetic poles. The inner insulating housing 16 isolates the penetrating member 18 and iron core 20 from the coils and provides a smooth, low friction guide surface. The penetrating member guide 22 further centers the penetrating member 18 and iron core 20. The penetrating member 18 is protracted and retracted by alternating the current between the first coil 12, the middle coil, and the third coil to attract the iron core 20. Reversing the coil sequence and attracting the core and penetrating member back into the housing retracts the penetrating member. The penetrating member guide 22 also serves as a stop for the iron core 20 mounted to the penetrating member 18. As discussed above, tissue penetration devices which employ spring or cam driving methods have a symmetrical or nearly symmetrical actuation displacement and velocity profiles on the advancement and retraction ofthe penetrating member as shown in Figures 2 and 3. In most ofthe available lancet devices, once the launch is initiated, the stored energy determines the velocity profile until the energy is dissipated. Controlling impact, retraction velocity, and dwell time ofthe penetrating member within the tissue can be useful in order to achieve a high success rate while accommodating variations in skin properties and minimize pain. Advantages can be achieved by taking into account ofthe fact that tissue dwell time is related to the amount of skin deformation as the penetrating member tries to puncture the surface ofthe skin and variance in skin deformation from patient to patient based on skin hydration. I ' ' " I In this embodiment, the ability to control velocity and depth of penetration may be achieved by use of a controllable force driver where feedback is an integral part of driver I I control. Such drivers can control either metal or polymeric penetrating members or any other type of tissue penetration element. The dynamic control of such a driver is illustrated in Figure. 2C which illustrates an embodiment of a controlled displacement profile and Figure 2D which illustrates an embodiment of a the controlled velocity profile. These are compared to Figures 2A and 2B, which illustrate embodiments of displacement and velocity profiles, respectively, of a harmonic spring/mass powered driver. Reduced pain can be achieved by using impact velocities of greater than about 2 m/s entry of a tissue penetrating element, such as a lancet, into tissue. Other suitable embodiments ofthe penetrating member driver are described in commonly assigned, copending U.S. Patent Application Ser. No. 10/127,395, (Attorney Docket No. 38187- 2551) filed April 19, 2002 and previously incorporated herein. Figure 3 illustrates the operation of a feedback loop using a processor 60. The processor 60 stores profiles 62 in non- volatile memory. A user inputs information 64 about the desired circumstances or parameters for a lancing event. The processor 60 selects a driver profile 62 from a set of alternative driver profiles that have been preprogrammed in the processor 60 based on typical or desired tissue! penetration device performance determined through testing at the factory or as programmed in by the operator. The processor 60 may customize by either scaling or modifying the profile based on additional user input information 64. Once the processor has chosen and customized the profile, the processor 60 is ready to modulate the power from the power supply 66 to the penetrating member driver 68 through an amplifier 70. The processor 60 may measure the location ofthe penetrating member 72 using a position sensing , mechanism 74 through an analog to digital converter 76 linear encoder or other such transducer. Examples of position sensing mechanisms have been described in the embodiments above and may be found in the specification for commonly assigned, copending U.S. Patent Application Ser. No. 10/127,395, (Attorney Docket No. 38187- 2551) filed April 19, 2002 and previously incorporated herein. The processor 60 calculates the movement ofthe penetrating member by comparing the actual profile ofthe penetrating member to the predetermined profile. The processor 60 modulates the power to the penetrating member driver 68 through a signal generator 78, which may control the amplifier 70 so that the actual velocity profile ofthe penetrating member does not exceed the predetermined profile by more than a preset error limit. The error limit is the accuracy in the control ofthe penetrating member. After the lancing event, the processor 60 can allow the user to rank the results of the lancing event. The processor 60 stores these results and constructs a database 80 for the individual user. Using the database 79, the processor 60 calculates the profile traits such as degree of painlessness, success rate, and blood volume for various profiles 62 depending on user input information 64 to optimize the profile to the individual user for subsequent lancing cycles. These profile traits depend on the characteristic phases of penetrating member advancement and retraction. The processor 60 uses these calculations to optimize profiles 62 for each user. In addition to user input information 64, an internal clock allows storage in the database 79 of information such as the time of day to generate a time stamp for the lancing event and the time between lancing events to anticipate the user's diurnal needs. The database stores information and statistics for each user and each profile that particular user uses. In addition to varying the profiles, the processor 60 can be used to calculate the appropriate penetrating member diameter and geometry suitable to realize the blood volume required by the user. For example, if the user requires about 1-5 microliter volume of blood, the processor 60 may select a 200 micron diameter penetrating member to achieve these results. For each class of lancet, both diameter and lancet tip geometry, is stored in the processor 60 to correspond with upper and lower limits of attainable blood volume based on the predetermined displacement and velocity profiles. The lancing device is capable of prompting the user for information at the beginning and the end ofthe lancing event to more adequately suit the user. The goal is to either change to a different profile or modify an existing profile. Once the profile is set, the force driving the penetrating member is varied during advancement and retraction to follow the profile. The method of lancing using the lancing device comprises selecting a profile, lancing according to the selected profile, determining lancing profile traits for each characteristic phase ofthe lancing cycle, and optimizing profile traits for subsequent lancing events. Figure 4 illustrates an embodiment of a tissue penetration device, more specifically, a lancing device 80 that includes a controllable driver 179 coupled to a tissue I ' ' " i penetration element. The lancing device 80 has a proximal end 81 and a distal end 82. At the distal end 82 is the tissue penetration element in the form of a penetrating member 83, which is coupled to an elongate coupler shaft 84 by a drive coupler' 85. The elongate coupler shaft 84 has a proximal end 86 and a distal end 87. A driver coil pack 88 is disposed about the elongate coupler shaft 84 proximal ofthe penetrating member 83. A position sensor 91 is disposed about a proximal portion 92 ofthe elongate coupler shaft

84 and an electrical conductor 94 electrically couples a processor 93 to the position sensor

91. The elongate coupler shaft 84 driven by the driver coil pack 88 controlled by the position sensor 91 and processor 93 form the controllable driver, specifically, a controllable electromagnetic driver. Referring to Figure 5, the lancing device 80 can be seen in more detail, in partial longitudinal section. The penetrating member 83 has a. proximal end 95 and a distal end 96 with a sharpened point at the distal end 96 ofthe penetrating member 83 and a drive head 98 disposed at the proximal end 95 ofthe penetrating member 83. A penetrating member shaft 201 is disposed between the drive head 98 and the sharpened point 97. The penetrating member shaft 201 may be comprised of stainless steel, or any other suitable material or alloy and have a transverse dimension of about 0.1 to about 0.4 mm. The penetrating member shaft may have a length of about 3 mm to about ;!50 mm, specifically, about 15 mm to about 20 mm. The drive head 98 ofthe penetrating member 83 is an enlarged portion having a transverse dimension greater than a transverse dimension of the penetrating member shaft 201 distal ofthe drive head 98. This configuration allows the drive head 98 to be mechanically captured by the drive coupler 85. The drive head 98 may have a transverse dimension of about 0.5 to about 2 mm. A magnetic member 102 is secured to the elongate coupler shaft 84 proximal of the drive coupler 85 on a distal portion 203 ofthe elongate coupler shaft 84. The magnetic member 102 is a substantially cylindrical piece of magnetic material having an axial lumen 204 extending the length ofthe magnetic member 102. The magnetic member 102 has an outer transverse dimension that allows the magnetic member 102 to slide easily within an axial lumen 105 of a low friction, possibly lubricious, polymer guide tube 105' disposed within the driver coil pack 88. The magnetic member 102 may have an outer transverse dimension of about 1.0 to about 5.0 mm, specifically, about 2.3 to about 2.5 mm. The magnetic member 102 may have a length of about 3.0 to about 5.0 mm, specifically, about 4.7 to about 4.9 mm. The magnetic member 102 can be made from a variety of magnetic materials including ferrous metals such as ferrous steel, iron, ferrite, or the like. The magnetic member 102 may be secured to the distal portion 203 of the elongate coupler shaft 84 by a variety of methods including adhesive or epoxy bonding, welding, crimping or any other suitable method. Proximal ofthe magnetic member 102, an optical encoder flag 206 is secured to the elongate coupler shaft 84. The optical encoder flag 206 is configured to move within a slot 107 in the position sensor 91. The slot 107 ofthe position sensor 91 is formed between a first body portion 108 and a second body portion 109 ofthe position sensor 91. The slot 107 may have separation width of about 1.5 to about 2.0 mm. The optical encoder flag 206 can have a length of about 14 to about 18 mm, a width of about 3 to about 5 mm and a thickness of about 0.04 to about 0.06 mm. The optical encoder flag 206 interacts with various optical beams generated by LEDs disposed on or in the position sensor body portions 108 and 109 in a predetermined manner. The interaction ofthe optical beams generated by the LEDs ofthe position sensor 91 generates a signal that indicates the longitudinal position ofthe optical flag 206 relative to the position sensor 91 with a substantially high degree of resolution. The resolution ofthe position sensor 91 may be about 200 to about 400 cycles per inch, specifically, about 350 to about 370 cycles per inch. The position sensor 91 may have a speed response time (position/time resolution) of 0 to about 120,000 Hz, where one dark and light stripe ofthe flag constitutes one Hertz, or cycle per second. The position ofthe optical encoder flag 206 relative to the magnetic member 102, driver coil pack 88 and position sensor 91 is such that the optical encoder 91 can provide precise positional information about the penetrating member 83 over the entire length ofthe penetrating member's power stroke. An optical encoder that is suitable for the position sensor 91 is a linear optical incremental encoder, model HEDS 9200, manufactured by Agilent Technologies. The model HEDS 9200 may have a length of about 20 to about 30 mm, a width of about 8 to about 12 mm, and a height of about 9 to about 11 mm. Although the position sensor 91 illustrated is a linear optical incremental encoder, other suitable position sensor embodiments could be used, provided they posses the requisite positional resolution and time response. The HEDS 9200 is a two channel device where the channels are 90 degrees out of phase with each other. This results in a resolution of four times the basic cycle ofthe flag. These quadrature outputs make it possible for the processor to determine the direction of penetrating member travel. Other suitable position sensors include capacitive encoders, analog reflective sensors, such as the reflective position sensor discussed above, and the like. . A coupler shaft guide 111 is disposed towards the proximal end 81 ofthe lancing device 80. The guide 111 has a guide lumen 112 disposed in^the guide 111 to slidingly accept the proximal portion 92 ofthe elongate coupler shaft 84. The guide 111 keeps the elongate coupler shaft 84 centered horizontally and vertically in the slot 102 ofthe optical encoder 91. In another aspect ofthe present invention, a still further embodiment of a body fluid sampling device will now be described. Additional details of a suitable body fluid sampling device can be found in commonly assigned, copending U.S. Patent Application Ser. No. (Attorney Docket No. 38187-2662) filed May 1, 2003, fully incorporated by reference for all purposes. Referring now to Figure 6, one embodiment of a sampling device 220 is shown. In this embodiment, a cartridge 222 have a disc shape may be used to house a plurality fo penetrating members 224 that may extend outward from an opening 226. A finger or other tissue may be placed at interface 228. It should be understood that a variety of different penetrating members may be used including but not limited to solid, elongate members or patent needle members. In this embodiment, a penetrating member driver 230 may be used to individually engage each penetrating member 224. The penetrating member driver 230 may include those described herein those described in commonly assigned, copending U.S. Patent Application Ser. No. 10/127,395 (Attorney Docket No. 38187-2551) filed April 19, 2002 or U.S. Patent Application Ser. No. 10/425,815 (Attorney Docket No. 38187-2663) filed May 30, 2003, each fully incorporated by reference for all purposes Referring now to Figure 7, a still further embodiment of a fluid sampling device 240 is shown. In this embodiment, a cartridge 242 is shown which may be inserted into the underside of the device 240. A front end 244 is shown. In this embodiment a solenoid may be used as the penetrating member driver. It should be understood that Figure 7 shows an exploded view ofthe components used in the present embodiment. A visual display 246 may be used for various reasons including but not limited to relaying information to the user, to display lancing performance, to provide device status, and other information as described in commonly assigned, copending U.S. Patent Application Ser. No. 10/237,261 (Attorney Docket No. 38187-2595) filed September 5, 2002 and U.S. Patent Application Ser. No. 10/335,215 (Attorney Docket No. 38187-2634), fully incorporated herein by reference. Referring now to Figures 8 and 9, top and bottom view of a chassis 250 for use with the device 240 is shown in further detail. Figure 8 shows various toothed surfaces 252. Figure 9 shows an underside with a recessed portion 254 for receiving a cartridge 242. The cartridge 242 may be rotated or indexed based on movement ofthe slider 256 (see Figure 7). Referring now to Figure 10, various cross-sectional views of one embodiment of a cartridge 242 according to the present invention is shown. It should be understood that the cartridge 242 may include a sterility barrier (not shown in Figure 10 for ease of illustration). It should be understood that all measurements and dimensions shown in Figure 10 are purely exemplary and other sizes may be used without departing from the spirit ofthe present invention. It should be understood that the dimensions near cross- section D are such that, in this embodiment, the penetrating member may be gripped or held in place by the cartridge, preventing the penetrating member from extending outward. Referring now to Figures 11, 12, and 13, top down, side and bottom view ofthe cartridge 242 are shown. Again, all dimensions are purely exemplary and other sizes may be used or varied without departing from the spirit ofthe present invention. As seen the cartridge 242 may include a notch 260 on the outer perimeter (Figure 13). This may be used for positioning ofthe cartridge 242 into the device. It may also be used for counting purposes, by tracking where this notch is, relative to the device 240, the number of penetrating members remaining may be calculated. The notch 260, in another device, maybe be used to align the cartridge 242 on a rotating disc or surface, where rotation of the surface is used to track the position ofthe cartridge 242 and the number of penetrating members remaining. As seen in Figures 12 and 13, the inner diameter may include notches 262 for position purposes and for purposes of turning or rotating the cartridge 242. I ' " ' I Referring now to Figure 14, a perspective view of an embodiment ofthe cartridge

242 is shown. As seen in Figure 14, penetrating members 224 are shown housed in the I I cartridge 242. Figure 14 also shows an embodiment where a toothed surface 264 is \ included on the inner circumference ofthe cartridge 242. j) Referring now to Figure 15, a still further embodiment of a cartridge according to the present invention will be described. As seen in Figure 15, this embodiment has a cartridge 270 with a sterility barrier 272 and a sensor layer 27^4. As seen Figure 15, the sensor layer 274 has a plurality of leads 276 which extend from sensor 278. In one embodiment, these leads 276 extend to the inner circumference to connect to couplers (not shown) the sampling device 240. As seen on layer 272, an arrow 273, triangle, circle, dot, square, or other orientation marker may be on the layer 272 or in other embodiments on the cartridge 270 (or cartridge 242) or on the layer 274 to facilitate positioning by the user. Referring now to Figure 16, a top down view is shown of one embodiment ofthe sensor layer 274. It should be understood the leads 276 may also be configured to extend short ofthe inner diameter. For ease of illustration, various configurations are shown on the same sensor layer 274. It should be understood that the leads on the sensor layer 274 may all have the same configuration, any combination ofthe configurations shown herein, or other configurations. The leads 280 may extend roughly halfway while leads 282 extend further. They may then engage various contact pads (not shown) on the device 240 which can engage the leads. A still ftirther embodiment has leads 284 that extend towards the outer circumference ofthe cartridge 242 to engage various contact pads or other connectors as known to those of skill in the art. Referring now to Figure 17, a still further embodiment ofthe present invention will be described. As seen in this embodiment, various visual markings may be made on the top surface and/or the bottom surface ofthe cartridge 290. Figure 17 only shows the top side ofthe cartridge 290, however, these same markings may also be made on the underside. Although not limited to the following, these markings may be in the form of colors, numbers, bar codes, or other markings. The embodiment in Figure 17 shows a region 292 that may be warning region indicating to the user that number of unused penetrating members are running low. The region 294 may be used to indicate that the penetrating members are almost all used. Although not limited to the following, these regions 294 may be color coded. The regions may also have certain properties that may be detectable by other sensors, such as but not limited to being magnetic or having other detectable properties. In some embodiments, the markings maybe be on portions directly opposite ofthe active region since the window 296 may be on the side ofthe cartridge that is not the active side. These markings may cover only a portion ofthe cartridge or the entire cartridge may contain markings that provide information. Binary or other machine readable information may also be placed on the cartridge and then detected by a reader in the device 240 for detecting status information based on how the cartridge is positioned. Referring now to Figure 18, a still further embodiment of a cartridge according to the present invention will be described. For ease of illustration, multiple elements are shown on the cartridge 300. It should be understood that the cartridge 300 and others described herein may include some, none, or all of these features. This cartridge may include a dessicant 302 that may be included in the cartridge 300 to absorb moisture that may enter therein. Dessicant 302 may be in the form of a pellet or other embodiment that is a separate element from the cartridge. In other embodiments, the dessicant 304 may be printed, deposited, or otherwise integrated to the cartridge 300. The dessicant 306 may be on the side surfaces of cavities in the cartridge 300. A still further embodiment has the dessicant 308 attached by some technique such as, but not limited to printing, adhering, forming, or other wise integrating the dessicant 308 to some material coupled to the cartridge, such as but not limited to the sterility barrier. These techniques may also be used to attach these dessicants to the cartridge or even the sensor layer. They may also be coupled to a separate layer of material attached to the cartridge that only covers a portion ofthe cartridge. A still further feature ofthe cartridge 300 is to include a separate test that the cartridge 300 may be rotated to if the processor on the device detects that the analyte readings from a regular test requires a specialized test to be conducted. The cartridge 300 will be rotated as indicated by arrow 309. As a nonlimiting example, if glucose readings are detected outside a desired range, a processor may recommend a HB1AC test be conducted. The cartridge 300 may then be rotated to designated position to align a cavity 310 with a sensor 312 for this test. This rotation may occur by mechanical actuation or by electric powered rotation ofthe cartridge. In this embodiment, each cartridge may I ' ' ' A have three HB1 AC tests. Other cartridges may have other numbers or they may have other test areas in place ofthe HB1 AC tests. Referring now to Figure 19, a still further embodiment of penetrating member coupler will now be described. In this embodiment, the coupler 320 is linked to an electrical source 322 that can be controlled to release a charge to sterilize a penetrating member coupled to the coupler 320. Thus, prior to use, the coupler 320 can sterilize the penetrating member before the member is driven into tissue. Figure 19 also shows a heating element 326 that may be used to melt a portion of the cartridge after the penetrating member has been actuated. This will hold the penetrating member in place and prevent the sharp from being released from the cartridge. The heating element 326 may be positioned at a cavity adjacent or in other embodiments, simply away from the active cavity. In other embodiments, the heating element 326 (shown in phantom) may be positioned over the activity cavity. Referring now to Figure 20, a still further embodiment ofthe present invention may use a processor 330 to detect the amount of force used a cutter 332 or a punch 334 to pierce the sterility barrier on the cartridge. Although not limited to the following, the amount of force may be used to detect if the cavity on the cartridge is a used and the sterility barrier has already been breached. j Referring now to Figure 21, a still further embodiment ofthe present invention will now be described. As seen in Figure 21, one embodiment of a cartridge 340 according to the present invention may not have a opening in the center like those cartridges shown in the previous figures. Figure 21 also shows various receptacles 342 and 344 shown in phantom. In this embodiment, the penetrating members are not parked in the cartridge after use. They may be actuated and then released. They may fall into container 344 through a slot in the bottom ofthe cartridge. Or they be dumped into the receptacle 342 after use. In some configurations, the user may simply grab the used penetrating member, pull it out ofthe cartridge, and deposit it into a receptacle. In a still further embodiment, a used penetrating member may be ejected from the cartridge during the process of loading a new penetrating member. The used penetrating member is ejected out into a receptacle 346. Referring now to Figure 22, another embodiment ofthe present invention will now be described. Figure 22 shows a method for use with a penetrating member driver 350 which is brought together with a multiple penetrating member cartridge 352 or single cartridge 354 only during use. After use, the cartridge and driver are separated for ease of storage, sterility, or other reasons. As seen, the cartridge 352 may be inserted into slot 358. Although not limited to the following, the penetrating member driver may be any of those described herein or the applications incorporated by reference. The driver may also be any of those described in commonly assigned, copending U.S. Patent Application Ser. No. 10/425,815 (Attorney Docket No. 38187-2663) filed May 30, 2003, fully incorporated herein by reference. In one embodiment, a case may be provided to store both the driver and the cartridge, or just the driver, or just the cartridge. Referring now to Figure 23, a plurality ofthe cartridges 352 are shown. Each may contain a penetrating member 360. These cartridge 352, in this embodiment, may be substantially equivalent to on cavity on the cartridge 242. The cartridge 352 may include an area that has sufficient interference fit to grip a penetrating member and it may have an elongate opening on one side, such as but not limited to top or bottom, to allow a penetrating member coupler to engage the penetrating member 360 therein. It should be understood, that in some embodiments, only proximal and distal end openings are provided. Referring now to the embodiment shown in Figure 24, a plurality of cartridges 352 are coupled together by some layer of material 362. They may use a sterility barrier to couple them together. In another embodiment, a mold plastic or polymer may be used to couple the cartridge 352 together. The cartridges maybe designed to allow access from the top as indicated by arrow 364 or from the bottom 366. Figure 25 shows a still further embodiment where a distal portion 370 is not covered by the sheet 362. In this embodiment, this is where a punch would come down and punch down material covering the front. Figure 26 shows an embodiment where the cartridges may be coupled into a configuration as shown. Referring now to Figures 27 and 28, embodiments of cartridges 352 coupled together is shown used with rollers 380 and a support surface 382 over the active region. A penetrating member coupler 384 may be used to engage penetrating members inside the cartridge 352. The cartridges may be rotated as indicated by arrows 386 to bring cartridges into alignment with the coupler 384. I ' " ' I Figure 28 shows a similar embodiment where the roller 388 has teeth 390 to engage spaces between the cartridges 352. The embodiment in Figure 28 allows the / ! coupler 384 to pierce tlirough the material 362 to engage the penetrating member therein. In one configuration, the punch and opening ofthe sterility barrier is very similar to those techniques used for cartridge 242. \ Figure 29 shows a still further embodiment where the cartridges 352 are in an elongate strung out configuration that may be layer on top of each other or otherwise configured to efficiently store the tape of cartridges 352. The embodiment of Figure 29 may include a cutter at the position indicated by dotted line 392 where the material 362 is cut and the used cartridge 352 may be discarded. The cutter (not shown) may any of those known to those of skill in the art. Referring now to Figure 30, a still further embodiment is shown where a penetrating member driver 400 may be coupled to cartridge 402 containing a plurality of penetrating members. The cartridge 402 may snap on the holder 404 and be held in place similar to that technique used by amaray or cases used to DVDs or CDs. A penetrating member 406 may be included. Figure 31 shows a still further embodiment where disc 420 holding the penetrating members are contained inside a housing 422. The housing 422 may be coupled to a penetrating member driver 424. Any ofthe drivers disclosed herein may be used for the driver 424. Again, the configurations here may teach a method of use where the penetrating members and drivers are brought together only when the sampling is about to occur. Referring now to Figures 32 through 37 show embodiments of cartridges for use with device 240. Figure 32 shows a full circular cartridge 440 with a reduced number of cavities 442 spaced apart on the cartridge. Figure 33 shows a single cartridge 450 holding a single penetrating member. Figure 34 shows a cartridge 460 having two wedge configuration. Figure 35 shows a cartridge 462 having a single cavity per finger 463. Of course in other embodiments, there may be more than one cavity in each finger. The entire cartridge may also be a partial circular configuration (half-circular, quarter circle, wedge, etc...). Figure 36 shows an embodiment of a cartridge 470 with a half circular or VΛ circular or wedge configuration. Figure 37A shows a cartridge 480 that may have portions, such as but not limited to quarters, thirds, or other fractions, on it that are colored or otherwise marked to show, as a nonlimiting example, number of penetrating members remain or the type of analyte test held therein. Figure 37B shows another embodiment wherein penetrating member cavities are only disposed over a wedge portion ofthe cartridge. In Figure 37C, the penetrating member cavities are very loosely dispersed over the cavity. Some embodiments may have one or more analyte detecting members 443 positioned to receive body fluid. Figures 38 to 82 show still further embodiments ofthe present invention.

2685 Referring now to Figure 83, another aspect ofthe present invention will now be described. One embodiment of a cartridge indexing device 610 is show. The indexing device 610 include a cam groove 612. It moves a cutting element (jsee Figure 88) that opens a sterility barrier covering the cartridge 620. As seen in Figure 83, the path of pusher 622 is at a diagonal as indicated by arrow 624. Thus, as the pusher 622 is advanced outward, it both cuts the sterility barrier and it rotates the cartridge 620 since the pusher 622 is moving at a diagonal. A slider 630 may be use by the user to advance and move the pusher 622. A penetrating member driver 640 may be coupled drive the penetrating member gripper 650. Figure 84 shows the penetrating member gripper 650 more clearly. This is the start and end position. As seen, the gripper 650 is in the cavity 652. The gripper 650 may be advanced outward as indicated by arrow 654 to direct the penetrating member into tissue. The punch 656, used to break the barrier covering the penetrating member exit, is in an up position to allow the penetrating member to exit. As seen in Figure 84, a second cam 660 is shown. The follower 662 is coupled to the sterility barrier cutter that cuts the barrier from the top and also rotates the cartridge 620. This cam 660 lowers the cutter on the forward stroke (to cut barrier and rotate cartridge) and raises it on! the return stroke (so it does not rotate the cartridge back). Figures 85 and 86 show the pusher 622. being advanced as indicated by arrow 670.

Figure 86 shows the pusher 622 fully advanced. As seen, the punch 656 has dropped to open the front sterility barrier. The cutter 680 has moved from a rear ofthe cavity (Figure 85) to a front ofthe cavity (Figure 86). Figure 87 shows a side view ofthe same position ofthe pusher 622 as that in Figure 86. As seen, the punch 656 has dropped, the cutter 680 has finished its stroke.

The follower 662 is in the top groove ofthe cam 660. When the follower 662 drops to the bottom groove, the cutter 680 will be raised. As seen, the gripper 650 is in a raised position and allows the cartridge 620 to rotate. Figure 88 is a close-up view ofthe second cam 660. It has a top groove 661 and bottom groove 663. The follower 662 travels through the grooves and flips the cutter 860 between up and down positions. In one embodiment, the follower 662 is in the top groove 661 in the forward stroke and in the bottom groove 663 in the backward stroke. Referring now to the embodiment of Figure 89, the follower 662 has now moved to the bottom groove 663 and the cutter 680 is moved to an up position. The penetrating member coupler 650 is still in the up position. Figure 90 shows the cutter 680 withdrawn, the punch 656 raised and the follower 662 in the bottom groove. In this embodiments, these motions are guided by cam surfaces. The coupler 650 is still raised. Referring now to Figure 91, the follower 662 reaches the end ofthe bottom groove 663. The follower 690 (on pusher 622) pushes down on a cam surface (not shown) that lowers the gripper 650. In this position, the gripper 650 engages a penetrating member in the cavity and can actuate the member outward as indicated by arrow 700. Figures 92 and 93 show still further views and embodiments of elements according to the present invention. This embodiment provides a simplified device the both indexes and cuts open the sterility barrier in a single motion. It should be understood that other element besides cams may be used to position the various elements. Rollers, gears, pulleys, electronic, or pneumatic actuators may be used. Some embodiments may use a pneumatic actuator to advance the penetrating member. The same or a separate pneumatic actuator may be used withdraw the penetrating member. Any other actuator may be used in combination with the pneumatic or other actuator to effect a fast in slow out profile. The devices may be used in place of device 640.

i ' " ' I 2686 In one embodiment as seen in Figure 94, a body fluid sampling device 710 for use { i with a cartridge containing a plurality of penetrating members is provided. The device

710 comprises a penetrating member driver 712 (shown in phantom in Figure 96) for moving an active one ofthe penetrating members outward as indicated by arrow 714 from a first position outward to penetrate tissue. A housing 714 is coupled to the driver. A display 716 on the housing shows a number 718 of unused penetrating members remaining. The penetrating member driver is coupled to a position sensor, said sensor used to detect a position ofthe active one of said penetrating member. In one embodiment, a body fluid sampling device for use with a cartridge containing a plurality of penetrating members is provided. The device comprises a penetrating member driver for moving an active one ofthe penetrating members from a first position outward to penetrate tissue. As seen in Figures 94 through 97, the housing 714 may have a rectangular configuration. In one embodiment, a body fluid sampling device for use with a cartridge containing a plurality of penetrating members is provided. The device comprises a penetrating member driver for moving an active one ofthe penetrating members from a first position outward to penetrate tissue. The housing 714 may have! a golden color. As seen in Figure 96, the position sensor 720 may be used to detect a position ofthe active one of said penetrating member. Referring now to Figure 98, one embodiment of an improved fluid sampling device 800 is shown. The device 800 includes a display 802, a penetrating member actuation button 804, adjustment buttons 806 and 808, and a front end annular ring 810. In this embodiment, a slider 812 is movable as indicated by arrow 814. A pop-open button 816 is provided and is movable as indicated by 818. This opens the device 800 as shown in Figure 99. This embodiment of device 800 may also include a see-through window 820 that allows a user to see a cartridge inside the device 800. It should be understood that this window 820 may be provided in a variety of shapes including the U- shaped configuration shown in Figure 97, a full circular window, a U-shaped window on the top portion or mirror-imaged upward from the configuration shown in Figure 97, comprise of a plurality of smaller windows, or otherwise configured or positioned to show a user that a cartridge is inside the device. Referring now to Figure 98, the metallic quality ofthe housing 814 may be observed. Referring now to Figure 99, in one embodiment, a body fluid sampling device for use with a cartridge containing a plurality of penetrating members is provided. The device comprises a penetrating member driver for moving an active one ofthe penetrating members from a first position outward to penetrate tissue. A cavity 750 to house the cartridge 830 containing said penetrating members, said cartridge being a circular disc having a fracturable sterility seal covering a top opening and a side opening. Referring now to Figure 99, the embodiment of device 800 is shown with the underside 840 hinged open. A battery 844 is shown in the compartment 842. The cartridge 830 is rotatable as indicated by arrow 846. It should be understood, of course, that the cartridge 830 may be designed to rotate in a counterclockwise direction in another embodiment. A rotatable gear 850 that is linked to slider 812, will rotate to rotate the cartridge 830. In the present embodiment, a support member 860 is provided to position the cartridge 830 in the areas where the penetrating member coupler 870 will engage the penetrating members. Although not limited to the following, the support member 860 is mounted on springs 862 which may allow the support to be moved downward and then urged back to its original position. Referring now to Figure 99, in one embodiment, a body fluid sampling device for use with a cartridge containing a plurality of penetrating members is provided. The device comprises a penetrating member driver for moving an active one ofthe penetrating members from a first position outward to penetrate tissue. The device allows for electronic setting of lancing parameters used by said penetrating member driver. A display 102 may be used to show the settings. Touch pads 180 and 182 may be used to receive input from buttons on the housing. In one embodiment, a body fluid sampling device for use with a cartridge containing a plurality of penetrating members is provided. The device comprises a penetrating member driver for moving an active one ofthe penetrating members from a first position outward to penetrate tissue. Settings for lancing parameters used by said penetrating member driver remain in memory without battery. As a nonlimiting example, nonvolatile memory may be used to store the settings. As another nonlimiting example, an EEPROM may be used. Referring now to Figure 100, in one embodiment, a body fluid sampling device 710 for use with a cartridge containing a plurality of penetrating members is provided. The device comprises a penetrating member driver 898 for moving an active one 900 of the penetrating members from a first position outward to penetrate jitissue. A processor 902 having a safety feature such that the penetrating member driver only lances material with properties similar to skin. Thus as seen in Figure 100, if the penetrating member 900 in this embodiment fails to decelerate or indicate resistance consistent with that of flesh or skin, the processor 902 will abort the lancing event. In one embodiment, a body fluid sampling device for use with a cartridge containing a plurality of penetrating members is provided. The device comprises a penetrating member driver for moving an active one ofthe penetrating members from a first position outward to penetrate tissue. A processor! 902 having a safety feature such that the penetrating member driver does not fire the active penetrating member in to air or materials harder than flesh. Thus if the penetrating member fails to sense resistance within a minimum distance such as about 100 microns, 75 microns, 50 microns, or other distance outward from the front end, then the controller will abort lancing event. Of course, other distances may be selected to be the stroke distance before the lancing event is aborted. :! Referring now to Figure 101, in one embodiment, a body fluid sampling device for use with a cartridge containing a plurality of penetrating members is provided. The device comprises a penetrating member driver for moving an active one ofthe penetrating members from a first position outward to penetrate tissue. A processor 902 may have a safety feature such that the penetrating member driver wherein a hard detect or an impact against material harder than tissue invalidates usage ofthe penetrating member 900. As seen in Figure 100, impact with a hard surface H may cause a spur 910 to form on the distal tip ofthe penetrating member. Such a penetrating member with a spur 910 or bent tip should not be used. In one embodiment, a body fluid sampling device for use with a cartridge containing a plurality of penetrating members is provided. The device comprises a penetrating member driver for moving an active one ofthe penetrating members from a first position outward to penetrate tissue. A display showing penetrating members left/penetrating members spent. A display such as that in Figure 94 could adapted for such use. In one embodiment, a body fluid sampling device for use with a cartridge containing a plurality of penetrating members is provided. The device comprises a penetrating member driver for moving an active one ofthe penetrating members from a first position outward to penetrate tissue. Depth setting of penetrating member penetration into tissue independent of front end geometry. The device of Figure 94 could be adapted for such use with the buttons on it for adjustments. In one embodiment, a body fluid sampling device for use with a cartridge containing a plurality of penetrating members is provided. The device comprises a penetrating member driver for moving an active one ofthe penetrating members from a first position outward to penetrate tissue. The device may include a processor programmed to track position and energy used by the driver to sense position or proximity of skin. Similar to the scheme shown in Figure 8, if the penetrating member fails to engage tissue or material with tissue like resistance, lancing event is aborted. In one embodiment, a body fluid sampling device for use with a cartridge containing a plurality of penetrating members is provided. The device comprises a penetrating member driver for moving an active one ofthe penetrating members from a first position outward to penetrate tissue. A display that has a screen saver may be used with the device. The device of Figure 94 could be adapted for such use. As a nonlimiting example, the Screensaver may be a small circle moving on the screen, a pattern being repeated on the display, or as other screen savers known to those of skill in the art. In one embodiment, a body fluid sampling device for use with a cartridge containing a plurality of penetrating members is provided. The device comprises a penetrating member driver for moving an active one ofthe penetrating members from a first position outward to penetrate tissue. A display may be provided that relays a "too deep" signal to a user based on the lancing event. The device of Figure 1 could be adapted for such use. Thus a processor 902 may determine that based on the resistance or other factors, the penetrating member went too deep. In some embodiments, this may also be based on whether the user indicated if blood was spontaneously generated, degree of pain felt, or other feedback. In other embodiments, the too deep indicator is based purely on tissue qualities detected by device and fed to the processor. " ' i ' ' " i In one embodiment, the lancing device is the first fully-automated and integrated lancing system. Simply hold it up to the skin and press of a button. Instantly and I, i painlessly a blood sample will appear. The device dramatically reduces the pain and inconvenience of other lancing systems. With a self-contained, sterile 50 lancet disk and fast, automatically controlled lancing a patient never needs to handle a new or used lancet again. They experience less pain and benefit from faster wound healing. In one embodiment, the lancing device is based on th^ "one-step, one-button" approach. Simply hold the device up to the skin and press the button. Instantly, a painless blood sample will appear. (One can milk if more blood is needed.) The lancing device incorporates a self-contained lancing disk that eliminates the need to load and discard lancets. The 50-lancet disk simply needs to be replaced after 50 uses. I As the first and only fully automated, self-contained lancing device, in one embodiment, the lancing device offers advantages over other lancing systems in 5 main areas: Pain, Convenience, Safety, Wound Healing, and Reliability. 1. Pain: Smart Lancing technology allows for fast, yet smooth electronically controlled lancing. Additionally, the lancing device is able to assess an individual's skin composition and only lance to lowest possible depth necessary to obt'ain an adequate sample. 2. & 3. Convenience and Safety: The device is completely self-contained and electronically controlled. The device only requires a user to press a single button to execute the entire lancing process. The device incorporates a self-contained, sterile 50- lancet disk so individuals with diabetes, most importantly children, will never see or handle a new or used lancet ever again. 4. Wound Healing: The fast, yet smooth electronically controlled lancing allows for minimal tissue damage and faster wound healing. 5. Reliability: The device eliminates the need for repetitive lancing due to insufficient blood samples. The lancing device results in an adequate blood sample nearly every single time. We recommend using the disk to completion. In one embodiment, however, a partially used Disk can be used. Once re-inserted the number of lancets remaining will be displayed on the screen and the device will be ready for use. In one embodiment, the lancing device is designed for the more convenient and physiologically accurate fingertip testing. Because the lancing device offers dramatically reduced pain and faster wound healing, AST is no longer necessary for patients. The lancmg device is designed for use by all individuals with diabetes and will be marketed to all individuals with diabetes who test their blood glucose levels. However, the lancing device is especially beneficial to children, who have sensitive skin and benefit the most from integrated convenience, safety, reduced pain, and faster wound healing. In one embodiment, the product is a "one-step, one button" fully integrated blood glucose sampling and measurement solution. This product combines the sample acquisition benefits ofthe lancmg device with superior measurement technology in one convenient device that will significantly reduce pain, eliminate daily medical waste, and provide superior monitoring reliability. Like the lancing device, the second-generation glucose sampling and measurement device is completely self-contained and fully automated. This will allow a patient to execute the entire sample acquisition and measurement process by pressing one button. Patients will no longer need to have separate lancing devices and glucose meters. This product will be the only device that individuals with diabetes will need for glucose monitoring activities. In addition to the reduced pain, increased convenience and enhanced reliability of the lancing device, this second-generation device also incorporates a replaceable combined test-strip/ lancet disk that eliminates the need for patients to load and discard lancets or test strips.

I ' ' " l

A plurality of conventional fluid sampling and specifically, glucose spot monitoring devices are shown. As a nonlimiting example, the one step solution ofthe present invention may combine the steps 1-7 into a single process to the user. In one embodiment, this may comprise pressing a single button to lance and obtain a blood glucose or other analyte reading. In other embodiments, the one step may be augmented by a step using>,a slider that is movable to load a new unused penetrating member in active position. In some embodiments, this may involve rotating the cartridge to bring the member into alignment with the penetrating member coupler. The evolution of integrated fluid sampling and monitoring devices will now be described. As seen, adaptive control may be added to a fluid sampling device to provide improved control of penetrating member depth. Adaptive control may involve an algorithm in the device controller which may take input from the user such as but not limited whether blood was spontaneously generated, pain level, sufficient blood generation, time of day during lancing, hydration ofthe user, location selected for lancing, or like from a lancing event. The algorithm will take these at least one of these variables and adjust the next lancing event to optimize lancing performance. Adjustments may include, but are not limited to, increasing or decreasing desired depth, adjusting velocity profile, changing braking force, changing coasting time, adjusting for tenting of tissue, or the like. It should be understood that other adjustments to penetrating member performance may be made to improve spontaneous blood generation or to reduce user pain. One embodiment of an improved fluid sampling device 1100 is shown. The device 1100 includes a display 1102, a penetrating member actuation button 1104, adjustment buttons 1106 and 1108, and a front end annular ring 1110. In this embodiment, a slider 1112 is movable as indicated by arrow 1114. A pop-open button 1116 is provided and is movable as indicated by 1118. This opens the device 1100 as shown in Figure 103. This embodiment of device 1100 may also include a see-through window 1120 that allows a user to see a cartridge inside the device 1100. It should be understood that this window 1120 may be provided in a variety of shapes including the U-shaped configuration shown in Figure 97, a full circular window, a U-shaped window on the top portion or mirror-imaged upward from the configuration, comprise of a plurality of smaller windows, or otherwise configured or positioned to show a user that a cartridge is inside the device. Referring now to Figure 102, close-up view is shown ofthe front end annular ring 1110. The cartridge 1130 with a sterility barrier can be seen through the front end. It should be understood that in some embodiments, the portion 1132 ofthe housing having the front end annular ring 1110 may be removed to allow the entire annular ring 1110 to be replaced either for cleaning purposes or for removal in its entirety. Referring now to Figure 103, a portion ofthe interior ofthe device 1100 is shown with the bottom portion 1140 being opened. A battery compartment 1142 is provided to house a power source for this embodiment ofthe device 1100. The embodiment of device 1100 is shown with the underside 1140 hinged open. A battery 1144 is shown in the compartment 1142. The cartridge 1130 is rotatable as indicated by arrow 1146. It should be understood, of course, that the cartridge 1130 may be designed to rotate in a counterclockwise direction in another embodiment. A rotatable gear 1150 (shown more clearly in Figure 106) that is linked to slider 1112, will rotate to rotate the cartridge 1130. In the present embodiment, a support member 1160 is provided to position the cartridge 1130 in the areas where the penetrating member coupler 1170 will engage the penetrating members. Although not limited to the following, the support member 1160 is mounted on springs 1162 which may allow the support to be moved downward and then urged back to its original position. In this embodiment as shown in Figure 104, this allows the penetrating member coupler 1170 to move downward in a longer stroke. The stroke length helps to ensure that the coupler 1170 engages the penetrating member in the cartridge 1130. The support member 1160 and the entire cartridge 1130 may be moved downward and upward as indicated by arrows 1172. The maximum downward position ofthe cartridge 1130 and the support member 1160 is shown in phantom. In the present embodiment, the support member 1160 is positioned to not interfere with the rotation ofthe cartridge 1130 but allows the cartridge 1130 be sufficient supported and positioned in place to allow a penetrating member coupler to accurately engage the cartridge 1130 and a penetrating member held therein. Referring now to Figure 105, a close-up top down view is shown of an embodiment of a cartridge 1130 according to the present invention. As seen in Figure I " ' I

104, the inner circumference may include a notch 1180 to facilitate positioning and/or rotation ofthe cartridge 1130. The cartridge 1130 may also include gear teeth 1182 to engage a corresponding gear on the gear 1150 shown in Figure 106. As seen in the Figure 104, the cartridge 1130 may include a park portion 1184 to jhold a penetrating member 1186 in the cartridge. The rear bearing 1188 will, in this embodiment, remain in guide contact with the penetrating member 1186 so that the penetrating member does not stray while it is being actuated. , Referring now to Figure 106, a close-up view is shown ofthe components used to engage and actuate a penetrating member. A penetrating member coupler 1170 is shown along with a punch 1190 used to open a sterility barrier covering the cartridge 1130 and keeping the penetrating member in a sterile condition prior to use. Further details on the function ofthe coupler 1170 and punch 1190 are discussed in U.S. Patent Application Attorney Docket No. 38187-2606. Gear 1150 will rotate to increment the cartridge 1130 as desired. Movement ofthe gear 1150 may be coupled to a slider 1112. It may not take much time to obtain a fluid sample and provide a reading. In one embodiment ofthe present invention, the device may provide a time of less than about 20 seconds using an electronic lancing device. The method may also be one that uses actuation based on a single button. Improved embodiments such as ( Ml and GM2 as seen in U.S. Patent Application Attorney Docket No. 38187-2662 fully incoφorated herein by reference may provide total times of less than about 15 seconds and less than about 10 seconds.

Referring now to Figure 107, a still further embodiment of a cartridge according to the present invention will be described. Figure 107 shows one embodiment of a cartridge 900 which may be removably inserted into an apparatus for driving penetrating members to pierce skin or tissue. The cartridge 900 has a plurality of penetrating members 902 that may be individually or otherwise selectively actuated so that the penetrating members 902 may extend outward from the cartridge, as indicated by arrow 904, to penetrate tissue. In the present embodiment, the cartridge 900 may be based on a flat disc with a number of penetrating members such as, but in no way limited to, (25, 50, 75, 100, ...) arranged radially on the disc or cartridge 800. It should be understood that although the cartridge 900 is shown as a disc or a disc-shaped housing, other shapes or configurations ofthe cartridge may also work without departing from the spirit ofthe present invention of placing a plurality of penetrating members to be engaged, singly or in some combination, by a penetrating member driver. Each penetrating member 902 may be contained in a cavity 906 in the cartridge 900 with the penetrating member's sharpened end facing radially outward and may be in the same plane as that ofthe cartridge. The cavity 906 may be molded, pressed, forged, or otherwise formed in the cartridge. Although not limited in this manner, the ends ofthe cavities 906 may be divided into individual fingers (such as one for each cavity) on the outer periphery ofthe disc. The particular shape of each cavity 906 may be designed to suit the size or shape ofthe penetrating member therein or the amount of space desired for placement ofthe analyte detecting members 808. For example and not limitation, the cavity 906 may have a V-shaped cross-section, a U-shaped cross-section, C-shaped cross- section, a multi-level cross section or the other cross-sections. The opening 810 through which a penetrating member 902 may exit to penetrate tissue may also have a variety of shapes, such as but not limited to, a circular opening, a square or rectangular opening, a U-shaped opening, a narrow opening that only allows the penetrating member to pass, an opening with more clearance on the sides, a slit, a configuration as shown in Figure 75, or the other shapes. In this embodiment, after actuation, the penetrating member 902 is returned into the cartridge and may be held within the cartridge 900 in a mamier so that it is not able to be used again. By way of example and not limitation, a used penetrating member may be returned into the cartridge and held by the launcher in position until the next lancing event. At the time ofthe next lancing, the launcher may disengage the used penetrating member with the cartridge 900 turned or indexed to the next clean penetrating member such that the cavity holding the used penetrating member is position so that it is not accessible to the user (i.e. turn away from a penetrating member exit opening). In some embodiments, the tip of a used penetrating member may be driven into a protective stop that hold the penetrating member in place after use. The cartridge 900 is replaceable with a new cartridge, 900 once all the penetrating members have been used or at such other time or condition as deemed desirable by the user. Referring still to the embodiment in Figure 107, the cartridge 900 may provide sterile environments for penetrating members via seals, foils, covers, polymeric, or similar materials used to seal the cavities and provide enclosed areas for the penetrating members to rest in. In the present embodiment, a foil or seal layer 920 is applied to one surface ofthe cartridge 900. The seal layer 920 may be made of a variety of materials such as a metallic foil or other seal materials and may be of a tensile strength and other quality that may provide a sealed, sterile environment until the seal layer 920 is penetrate by a suitable or penetrating device providing a preselected or selected amount offeree to open the sealed, sterile environment. Each cavity 906 may be individually sealed with a layer 920 in a mamier such that the opening of one cavity does not in erfere with the sterility in an adjacent or other cavity in the cartridge 800. As seen in the embodiment of Figure 107, the seal layer 920 may be a planar material that is adhered to a top surface of the cartridge 800. Depending on the orientation ofthe cartridge 900 in the penetrating member driver apparatus, the seal layer 920 may be on the top surface, side surface, bottom surface, or other positioned surface. For ease of illustration and discussion ofthe embodiment of Figure 107, the layer 920 is placed on a top surface ofthe cartridge 800. The cavities 906 holding the penetrating members 902 are sealed on by the foil layer 920 and thus create the sterile environments for the penetrating members. The foil layer 920 may seal a plurality of cavities 906 or only a select number of cavities as desired. In a still further feature of Figure 107, the cartridge 900 may optionally include a plurality of analyte detecting members 908 on a substrate 922 which may be attached to a bottom surface ofthe cartridge 900. The substrate may be made of a material such as, but not limited to, a polymer, a foil, or other material suitable for attaching to a cartridge and ' I holding the analyte detecting members 908. As seen in Figure 107, the substrate 922 may hold a plurality of analyte detecting members, such as but not limited to, about 10-50, 50- 100, or other combinations of analyte detecting members. This facilitates the assembly and integration of analyte detecting members 908 with cartridge 900. These analyte 5 detecting members 908 may enable an integrated body fluid sampling system where the penetrating members 902 create a wound tract in a target tissue, which expresses body fluid that flows into the cartridge for analyte detection by at least one ofthe analyte detecting members 908. The substrate 922 may contain any number of analyte detecting members 908 suitable for detecting analytes in cartridge having a plurality of cavities 10 906. In one embodiment, many analyte detecting members 908 may be printed onto a single substrate 922 which is then adhered to the cartridge to facilitate manufacturing and simplify assembly. The analyte detecting members 908 may be electrochemical in nature. The analyte detecting members 908 may further contain enzymes, dyes, or other detectors which react when exposed to the desired analyte. Additionally, the analyte detecting 15 members 908 may comprise of clear optical windows that allow light to pass into the body fluid for analyte analysis. The number, location, and type of analyte detecting member 908 may be varied as desired, based in part on the design ofthe cartridge, number of analytes to be measured, the need for analyte detecting member calibration, and the sensitivity ofthe analyte detecting members. If the cartridge 900 uses an analyte 20 detecting member arrangement where the analyte detecting members are on a substrate attached to the bottom ofthe cartridge, there may be through holes (as shown in Figure 76), wicking elements, capillary tube or other devices on the cartridge 900 to allow body fluid to flow from the cartridge to the analyte detecting members 908 for analysis. In other configurations, the analyte detecting members 908 may be printed, formed, or 25 otherwise located directly in the cavities housing the penetrating members 902 or areas on the cartridge surface that receive blood after lancing. The use ofthe seal layer 920 and substrate or analyte detecting member layer 822 may facilitate the manufacture of these cartridges 10. For example, a single seal layer 920 may be adhered, attached, or otherwise coupled to the cartridge 900 as indicated by 30 arrows 924 to seal many ofthe cavities 906 at one time. A sheet 922 of analyte detecting members may also be adhered, attached, or otherwise coupled to the cartridge 900 as indicated by arrows 925 to provide many analyte detecting members on the cartridge at ' i " ' " i one time. During manufacturing of one embodiment ofthe present invention, the cartridge 900 may be loaded with penetrating members 902, sealed with layer 920 and a temporary layer (not shown) on the bottom where substrate 922 would later go, to provide a sealed environment for the penetrating members. This assembly pith the temporary bottom layer is then taken to be sterilized. After sterilization, the assembly is taken to a clean room (or it may already be in a clear room or equivalent environment) where the temporary bottom layer is removed and the substrate 922 with analyte detecting members is coupled to the cartridge as shown in Figure 107. This process allows for the sterile assembly ofthe cartridge with the penetrating members 902 using processes and/or temperatures that may degrade the accuracy or functionality ofthe analyte detecting members on substrate 922. As a nonlimiting example, the entire cartridge 900 may then be placed in a further sealed container such as a pouchj bag, plastic molded container, etc...to facilitate contact, improve ruggedness, and/or allow for easier handling. In some embodiments, more than one seal layer 920 may be used to seal the cavities 906. As examples of some embodiments, multiple layers may be placed over each cavity 906, half or some selected portion ofthe cavities may be sealed with one layer with the other half or selected portion ofthe cavities sealed with another sheet or layer, different shaped cavities may use different seal layer, or the lik!e. The seal layer 920 may have different physical properties, such as those covering the penetrating members 902 near the end ofthe cartridge may have a different color such as red to indicate to the user (if visually inspectable) that the user is down to say 10, 5, or other number of penetrating members before the cartridge should be changed out. Referring now to Figure 108, one embodiment of an apparatus 980 using a radial cartridge 900 with a penetrating member driver 982 is shown. A contoured surface 884 is located near a penetrating member exit port 986, allowing for a patient to place their finger in position for lancing. Although not shown, the apparatus 980 may include a human readable or other type of visual display to relay status to the user. The display may also show measured analyte levels or other measurement or feedback to the user without the need to plug apparatus 980 or a separate test strip into a separate analyte reader device. The apparatus 980 may include a processor or other logic for actuating the penetrating member or for measuring the analyte levels. The cartridge 900 may be loaded into the apparatus 980 by opening a top housing ofthe apparatus which may be hinged or removably coupled to a bottom housing. The cartridge 900 may also drawn into the apparatus 980 using a loading mechanism similar in spirit to that found on a compact disc player or the like. In such an embodiment, the apparatus may have a slot (similar to a CD player in an automobile) that allows for the insertion ofthe cartridge 900 into the apparatus 980 which is then automatically loaded into position or otherwise seated in the apparatus for operation therein. The loading mechanism may be mechanically powered or electrically powered. In some embodiments, the loading mechanism may use a loading tray in addition to the slot. The slot may be placed higher on the housing so that the cartridge 900 will have enough clearance to be loaded into the device and then dropped down over the penetrating member driver 982. The cartridge 900 may have an indicator mark or indexing device that allows the cartridge to be properly aligned by the loading mechanism or an aligning mechanism once the cartridge 900 is placed into the apparatus 980. The cartridge 900 may rest on a radial platform that rotates about the penetrating member driver 982, thus providing a method for advancing the cartridge to bring unused penetrating members to engagement with the penetrating member driver. The cartridge 800 on its underside or other surface, may shaped or contoured such as with notches, grooves, tractor holes, optical markers, or the like to facilitate handling and/or indexing of the cartridge. These shapes or surfaces may also be varied so as to indicate that the cartridge is almost out of unused penetrating members, that there are only five penetrating members left, or some other cartridge status indicator as desired. A suitable method and apparatus for loading penetrating members has been described previously in commonly assigned, copending U.S. patent applications Attorney Docket 38187-2589 and 38187-2590, and are included here by reference for all purposes. Suitable devices for engaging the penetrating members and for removing protective materials associated with the penetrating member cavity are described in commonly assigned, copending U.S. patent applications Attorney Docket 38187-2601 and 38187- 2602, and are included here by reference for all purposes. For example in the embodiment of Figure 107, the foil or seal layer 920 may cover the cavity by extending across the cavity along a top surface 990 and down along the angled surface 892 to provide a sealed, sterile environment for the penetrating member and sensors therein. A piercing element described in U.S. patent applications Attorney Docket 38187-2602 has a piercing element and then a shaped portion behind the element which pushes the foil to " I ' " ' I the sides ofthe cavity or other position so that the penetrating member 902 may be actuated and body fluid may flow into the cavity. Referring now to Figure 39, one embodiment of a device that may use a disc 900 is shown. This embodiment of device 1000 include a display 1002, that shows lancing performance and setting such as penetration depth setting the like. Various buttons 1004 may also be placed on the housing to adjust settings and/or to activate lancing. It should be understood that device 1000 may include^ a processor for implementing any ofthe control methodologies set forth herein. The processor may control the penetrating member driver and/or active braking device such a pads, stops, dampers, dashpots and other mechanism to control penetrating member speed. The characteristic phases of penetrating member advancement and retraction can be plotted on a graph of force versus time illustrating the force exerted by the penetrating member driver on the penetrating member to achieve the desired displacement and velocity profile. The characteristic phases are the penetrating member introduction phase A-C where the penetrating member is longitudinally advanced into the skin, the penetrating member rest phase D where the penetrating member terminates its longitudinal movement reaching its maximum depth and becoming relatively stationary, and the penetrating member retraction phase E-G where the penetrating member is longitudinally retracted out ofthe skin. The duration ofthe penetrating member retraction phase E-G is longer than the duration ofthe penetrating member introduction phase A-C, which in turn is longer than the duration ofthe penetrating member rest phase D. The introduction phase further comprises a penetrating member launch phase prior to A when the penetrating member is longitudinally moving through air toward the skin, a tissue contact phase at the beginning of A when the distal end ofthe penetrating member makes initial contact with the skin, a tissue deformation phase A when the skin bends depending on its elastic properties which are related to hydration and thickness, a tissue lancing phase which comprises when the penetrating member hits the inflection point on the skin and begins to cut the skin B and the penetrating member continues cutting the skin C. The penetrating member rest phase D is the limit ofthe penetration ofthe penetrating member into the skin. Pain is reduced by minimizing the duration ofthe penetrating member introduction phase A-C so that there is a fast incision to a certain penetration depth regardless ofthe duration ofthe deformation phase A and inflection point cutting B which will vary from user to user. Success rate is increased by measuring the exact depth of penetration from inflection point B to the limit of penetration in the penetrating member rest phase D. This measurement allows the penetrating member to always, or at least reliably, hit the capillary beds which are a known distance underneath the surface ofthe skin. , The penetrating member retraction phase further comprises a primary retraction phase E when the skin pushes the penetrating member out ofthe wound tract, a secondary retraction phase F when the penetrating member starts to become dislodged and pulls in the opposite direction ofthe skin, and penetrating member exit phase G when the penetrating member becomes free ofthe skin. Primary retraction is the result of exerting a decreasing force to pull the penetrating member out ofthe skin as the penetrating member pulls away from the finger. Secondary retraction is the result of exerting a force in the opposite direction to dislodge the penetrating member. Control is necessary to keep the wound tract open as blood flows up the wound tract. Blood volume is increased by using a uniform velocity to retract the penetrating member during the penetrating member retraction phase E-G regardless ofthe force required for the primary retraction phase. E or secondary retraction phase F, either of which may vary from user to user depending on the properties ofthe user's skin. Displacement versus time profile of a penetrating member for a controlled penetrating member retraction can be plotted. Velocity vs. time profile ofthe penetrating member for the controlled retraction cairn also be plotted. The penetrating member driver controls penetrating member displacement and velocity at several steps in the lancing cycle, including when the penetrating member cuts the blood vessels to allow blood to pool 2130, and as the penetrating member retracts, regulating the retraction rate to allow the blood to flood the wound tract while keeping the wound flap from sealing the chaimel 2132 to permit blood to exit the wound. The tenting process and retrograde motion ofthe penetrating member during the lancing cycle can be illustrated graphically which shows both a velocity versus time graph and a position versus time graph of a penetrating member tip during a lancing cycle that includes elastic and inelastic tenting. From point 0 to point A, the penetrating member is being accelerated from the initialization position or zero position. From point A to point B, the penetrating member is in ballistic or coasting mode, with no additional I ' " " I power being delivered. At point B, the penetrating member tip contacts the tissue and begins to tent the skin until it reaches a displacement C. As the penetrating member tip I i approaches maximum displacement, braking force is applied to the penetrating member until the penetrating member comes to a stop at point D. The penetrating member then recoils in a retrograde direction during the settling phase ofthe lancing cycle indicated between D and E. Note that the magnitude of inelastic tenting indicated in Figure 148 is exaggerated for purposes of illustration. , The amount of inelastic tenting indicated by Z tends to be fairly consistent and small compared to the magnitude ofthe elastic tenting. Generally, the amount of inelastic tenting Z can be about 120 to about 140 microns. As the magnitude ofthe inelastic tenting has a fairly constant value and is small compared to the magnitude ofthe elastic tenting for most patients and skin types, the value for the total amount of tenting for the penetration stroke ofthe penetrating member is effectively equal to the rearward displacement ofthe penetrating member during the settling phase as measured by the processor 193 plus a predetermined value for the inelastic recoil, such as 130 microns. Inelastic recoil for some embodiments can be about 100 to about 200 microns. The ability to measure the magnitude of skin tenting for a patient is important to controlling the depth of penetration ofthe penetrating member tip as the skin is generally known to vary in elasticity and other parameters due to age, time of day, level of hydration, gender and pathological state. This value for total tenting for the lancing cycle can then be used to determine the various characteristics ofthe patient's skin. Once a body of tenting data is obtained for a given patient, this data can be analyzed in order to predict the total penetrating member displacement, from the point of skin contact, necessary for a successful lancing procedure. This enables the tissue penetration device to achieve a high success rate and minimize pain for the user. A rolling average table can be used to collect and store the tenting data for a patient with a pointer to the last entry in the table. When a new entry is input, it can replace the entry at the pointer and the pointer advances to the next value. When an average is desired, all the values are added and the sum divided by the total number of entries by the processor 193. Similar teclmiques involving exponential decay (multiply by .95, add 0.05 times current value, etc.) are also possible. With regard to tenting of skin generally, some typical values relating to penetration depth are now discussed. A cross sectional view ofthe layers ofthe skin can be shown. In order to reliably obtain a useable sample of blood from the skin, it is desirable to have the penetrating member tip reach the venuolar plexus ofthe skin. The stratum corneum is typically about 0.1 to about 0.6 mm thick and the distance from the top ofthe dermis to the venuole plexus can be from about 0.3 to about 1.4 mm. Elastic tenting can have a magnitude of up to about 2 mm or so, specifially, about 0.2 to about 2.0 mm, with an average magnitude of about 1 mm. This means that the amount of penetrating member displacement necessary to overcome the tenting can have a magnitude greater than the thickness of skin necessary to penetrate in order to reach the venuolar plexus. The total penetrating member displacement from point of initial skin contact may have an average value of about 1.7 to about 2.1 mm. In some embodiments, penetration depth and maximum penetration depth may be about 0.5 mm to about 5 mm, specifically, about 1 mm to about 3 mm. In some embodiments, a maximum penetration depth of about 0.5 to about 3 mm is useful. In some embodiments, the penetrating member is withdrawn with less force and a lower speed than the force and speed during the penetration portion ofthe operation cycle. Withdrawal speed ofthe penetrating member in some embodiments can be about 0.004 to about 0.5 m/s, specifically, about 0.006 to about 0.01 m/s. In other embodiments, useful withdrawal velocities can be about 0.001 to about 0.02 meters per second, specifically, about 0.001 to about 0.01 meters per second. For embodiments that use a relatively slow withdrawal velocity compared to the penetration velocity, the withdrawal velocity may up to about 0.02 meters per second. For such embodiments, a ratio ofthe average penetration velocity relative to the average withdrawal velocity can be about 100 to about 1000. In embodiments where a relatively slow withdrawal velocity is not important, a withdrawal velocity of about 2 to about 10 meters per second may be used. Another example of an embodiment of a velocity profile for a penetrating member can be seen shown, which illustrates a penetrating member profile with a fast entry velocity and a slow withdrawal velocity. A lancing profile showing velocity ofthe penetrating member versus position. The lancing profile starts at zero time and position and shows acceleration ofthe penetrating member towards the tissue from the I ' ' " ' I electromagnetic force generated from the electromagnetic driver. At point A, the power is shut off and the penetrating member begins to coast until it reaches the skin indicated i by B at which point, the velocity begins to decrease. At point C, the penetrating member has reached maximum displacement and settles momentarily, typically for a time of about 8 milliseconds. . A retrograde withdrawal force is then imposed on the penetrating member by the controllable driver, which is controlled by the processor to maintain a withdrawal velocity of no more than about 0.006 to about 0.01 meters/second. The same cycle is illustrated in the velocity versus time plotwhere the penetrating member is accelerated from the start point to point A. The penetrating member coasts from A to B where the penetrating member tip contacts tissue 233. The penetrating member tip then penetrates the tissue and slows with braking force eventually applied as thβi maximum penetration depth is approached. The penetrating member is stopped and settling between C and D. At D, the withdrawal phase begins and the penetrating member is slowly withdrawn until it returns to the initialization point shown by E. Note that retrograde recoil from elastic and inelastic tenting was not shown in the lancing profiles for purpose of illustration and clarity. In another embodiment, the withdrawal phase may use a dual;! speed profile, with the slow .006 to .01 meter per second speed used until the penetrating member is withdrawn past the contact point with the tissue, then a faster speed of .01 to 1 meters per second may be used to shorten the complete cycle. Referring now to Figure 110, yet another aspect ofthe present invention will now be described. To bring a new, unused penetrating member to use, the cartridge 1500 may be rotated as indicated by arrow 1502. A linear slider 1510 moves forward and backward as indicated by arrow 1512. The forward motion ofthe slider 1510 rotates the cartridge, among other things. In some embodiments, backward motion may be used to rotate the cartridge (it all depends on where the slider starts). Rotation occurs when a keyed gear (not shown) that the opening 1514 fits over is rotated by motion ofthe slider 1510. Of course, the slider 1510 in the present embodiment also actuates a plurality of other motions such as clearing the gripper, shield, and drive assembly, to lift them clear so that the cartridge 1500 can rotate. Referring now to Figure 111 shows how movement ofthe slider 1510 moves rod 1520 as indicate by arrows 1522. For ease of illustration, certain portions ofthe device are removed to allow easier visualization ofthe moving parts. The motion of rod 1522 causes a second slider 1530 to move as indicated by arrow 1532 and engage a stub 1534 on the rotating wheel 1540. This wheel 1540 turns the gear the fits inside the opening 1514. which rotates the cartridge. In the present embodiment, a roller 1550 also travels on a cam surface 1552. Some of these elements are more clearly illustrated in Figures 7 through 9. As seen in Figure 112, the roller 1550 also move a slider 1560. The rod 1520 also includes yet another roller 1562. This roller as seen in Figure 113, follows another cam surface 1570. The cam surfaces 1552 (Figure 111) and 1570 (Figure 113) allow for raising and lowering ofthe punch, shield, gripper, drive assembly, etc...to allow for the cartridge to rotate and a new penetrating member cavity to be opened and a member loaded for firing. In some embodiments, the various steps that need to happen are similar to those described in commonly assigned copending U.S. Patent Applications Ser. No. 10/323,623 (Attorney Docket No. 38187-2607) filed December 18, 2002. Figure 114 shows still further embodiments ofthe present invention. It more clearly shows some ofthe elements such as roller 1562. Embodiments using the linear motion ofthe slider 1510 and linear motion ofthe rod 1520 pushing linear sliders and pushing rollers to follow linear cam surfaces are very robust and will not easily fail. In some embodiments, the sequence involves raising the gripper ofthe penetrating member driver to disengage the penetrating member, raise it out ofthe way to allow the cartridge to rotate. Simultaneously or before rotation, a punch will open the next cavity to be used for a lancing event. With gripper out ofthe way, the cartridge is rotated and the gripper and newly opened cavity are aligned. The gripper is then lowered to engage the new penetrating member in the cartridge cavity. Some embodiments may just lower and/raise the gripper. Other embodiments raise and lower the gripper and the entire penetrating member driver. While the invention has been described and illustrated with reference to certain particular embodiments thereof, those skilled in the art will appreciate that various adaptations, changes, modifications, substitutions, deletions, or additions of procedures and protocols may be made without departing from the spirit and scope ofthe invention. For example, with any ofthe above embodiments, the location ofthe penetrating member drive device may be varied, relative to the penetrating members or the cartridge. With any ofthe above embodiments, the penetrating member tips may be uncovered during actuation (i.e. penetrating members do not pierce the penetrating mpmber enclosure or protective foil during launch). With any of the. above embodiments, the penetrating members may be a bare penetrating member during launch. With any ofthe above embodiments, the penetrating members may be bare penetrating members prior to launch as this may allow for significantly tighter densities of penetrating members. In some embodiments, the penetrating members may be bent, curved, textured, shaped, or otherwise treated at a proximal end or area to facilitate handling by an actuator. The penetrating member may be configured to have a notch or groove to facilitate coupling to a gripper. The notch or groove may be formed along an elongate portion ofthe penetrating member. With any ofthe above embodiments, the cavity may be on the bottom or the top ofthe cartridge, with the gripper on the other side. In some embodiments, analyte detecting members may be printed on the top, bottom, or side of the cavities. The front end ofthe cartridge maybe in contact with a user during lancing. The same driver may be used for advancing and retraction ofthe penetrating member. The penetrating member may have a diameters and length suitable fq{r obtaining the blood volumes described herein. The penetrating member driver may also be in substantially the same plane as the cartridge. The driver may use a through hole or other opening to engage a proximal end of a penetrating member to actuate the penetrating member along a path into and out ofthe tissue. The present penetrating member may be used with multiple penetrating member cartridges or single penetrating member cartridges. They may be used with penetrating member cartridges which are oval, square, rectangular, triangular, hexagonal, polygonal, or other shaped or combinations of shapes. The penetrating members may be used in a bandolier configuration or held in a tape containing a plurality of penetrating members between two tapes. The penetrating members may be used electric drive devices or conventional spring-based launchers. While the invention has been described and illustrated with reference to certain particular embodiments thereof, those skilled in the art will appreciate that various adaptations, changes, modifications, substitutions, deletions, or additions of procedures and protocols may be made without departing from the spirit and scope ofthe invention. For example, with any ofthe above embodiments, the location ofthe penetrating member drive device may be varied, relative to the penetrating members or the cartridge. With any ofthe above embodiments, the penetrating member tips may be uncovered during actuation (i.e. penetrating members do not pierce the penetrating member enclosure or protective foil during launch). With any ofthe above embodiments, the penetrating members may be a bare penetrating member during launch. With any ofthe above embodiments, the penetrating members may be bare penetrating members prior to launch as this may allow for significantly tighter densities of penetrating members. In some embodiments, the penetrating members may be bent, curved, textured, shaped, or otherwise treated at a proximal end or area to facilitate handling by an actuator. The penetrating member may be configured to have a notch or groove to facilitate coupling to a gripper. The notch or groove may be formed along an elongate portion ofthe penetrating member. With any ofthe above embodiments, the cavity may be on the bottom or the top ofthe cartridge, with the gripper on the other side. In some embodiments, analyte detecting members may be printed on the top, bottom, or side of the cavities. The front end ofthe cartridge maybe in contact with a user during lancing. The same driver may be used for advancing and retraction ofthe penetrating member. The penetrating member may have a diameters and length suitable for obtaining the blood volumes described herein. The penetrating member driver may also be in substantially the same plane as the cartridge. The driver may use a through hole or other opening to engage a proximal end of a penetrating member to actuate the penetrating member along a path into and out ofthe tissue. Any ofthe features described in this application or any reference disclosed herein may be adapted for use with any embodiment ofthe present invention. For example, the devices ofthe present invention may also be combined for use with injection penetrating members or needles as described in commonly assigned, copending U.S. Patent Application Ser. No. 10/127,395 (Attorney Docket No. 38187-2551) filed April 19, 2002. l ' ' " i

An analyte detecting member to detect the presence of foil may also be included in the > lancing apparatus. For example, if a cavity has been used before, the foil or sterility / barrier will be punched. The analyte detecting member can detect if the cavity is fresh or not based on the status ofthe barrier. It should be understood that in optional embodiments, the sterility barrier may be designed to pierce a sterility barrier of thickness that does not dull a tip ofthe penetrating member. The lancing apparatus may also use improved drive mechanisms. For example, a solenoid force generator may be improved to try to increase the amount of force the solenoid can generate for a given current. A solenoid for use with the present invention may have five coils and in the present embodiment the slug is roughly the size of two coils. One change is to increase the thickness ofthe outer metal shell or windings surround the coils. By increasing the thickness, the flux will also be increased. The slug may be split; two smaller slugs may also be used and offset by x/ι of a coil pitch. This allows more slugs to be approaching a coil where it could be accelerated. This creates more events where a slug is approaching a coil, creating a more efficient system. In another optional alternative embodiment, a gripper in the inner end ofthe protective cavity may hold the penetrating member during shipment and after use, eliminating the feature of using the foil, protective end, or other part o retain the used penetrating member. Some other advantages ofthe disclosed embodiments and features of additional embodiments include: same mechanism for transferring the used penetrating members to a storage area; a high number of penetrating members such as 25, 50, 75, 100, 500, or more penetrating members may be put on a disk or cartridge; molded body about a lancet becomes unnecessary; manufacturing of multiple penetrating member devices is simplified through the use of cartridges; handling is possible of bare rods metal wires, without any additional structural features, to actuate them into tissue; maintaining extreme (better than 50 micron -lateral- and better than 20 micron vertical) precision in guiding; and storage system for new and used penetrating members, with individual cavities/slots is provided. The housing ofthe lancing device may also be sized to be ergonomically pleasing. In one embodiment, the device has a width of about 56 mm, a length of about 105 mm and a thickness of about 15 mm. Additionally, some embodiments ofthe present invention may be used with non-electrical force generators or drive mechanism. For example, the punch device and methods for releasing the penetrating members from sterile enclosures could be adapted for use with spring based launchers. The gripper using a frictional coupling may also be adapted for use with other drive technologies. Still further optional features may be included with the present invention. For example, with any ofthe above embodiments, the location ofthe penetrating member drive device may be varied, relative to the penetrating members or the cartridge. With any ofthe above embodiments, the penetrating member tips may be uncovered during actuation (i.e. penetrating members do not pierce the penetrating member enclosure or protective foil during launch). The penetrating members may be a bare penetrating member during launch. In some embodiments, the penetrating member may be a patent needle. The same driver may be used for advancing and retraction ofthe penetrating member. Different analyte detecting members detecting different ranges of glucose concentration, different analytes, or the like may be combined for use with each penetrating member. Non-potentiometric measurement techniques may also be used for analyte detection. For example, direct electron transfer of glucose oxidase molecules adsorbed onto carbon nanotube powder microelectrode may be used to measure glucose levels. In some embodiments, the analyte detecting members may formed to flush with the cartridge so that a "well" is not formed. In some other embodiments, the analyte detecting members may formed to be substantially flush (within 200 microns or 100 microns) with the cartridge surfaces. In all methods, nanoscopic wire growth can be carried out via chemical vapor deposition (CVD). In all ofthe embodiments ofthe invention, preferred nanoscopic wires may be nanotubes. Any method useful for depositing a glucose oxidase or other analyte detection material on a nanowire or nanotube may be used with the present invention. Additionally, for some embodiments, any ofthe cartridge shown above may be configured without any ofthe penetrating members, so that the cartridge is simply an analyte detecting device. Still further, the indexing ofthe cartridge may be such that adjacent cavities may not necessarily be used serially or sequentially. As a nonlimiting example, every second cavity may be used sequentially, which means that the cartridge will go through two rotations before every or substantially all ofthe cavities are used. As another nonlimiting example, a cavity that is 3 cavities away, 4 cavities away, or N cavities away may be the next one used. This may allow for greater separation between cavities containing penetrating members that were just used and a fresh penetrating member to be used next. For any ofthe embodiments herein, they may be configured to provide the various velocity profiles described. This application cross-references commonly assigned copending U.S. Patent Applications Ser. No. 10/323,622 (Attorney Docket No. 38187-26(^6) filed December 18, 2002; commonly assigned copending U.S. Patent Applications Ser. No. 10/323,623 (Attorney Docket No. 38187-2607) filed December 18, 2002; and commonly assigned copending U.S., Patent Applications Ser. No. 10/323,624 (Attorney Docket No. 38187- 2608) filed December 18, 2002. This application is also related to commonly assigned copending U.S. Patent Applications Ser. Nos. 10/335,142, 10/335,215, 10/335,258, 10/335,099, 10/335,219, 10/335,052, 10/335,073, 10/335,220, 10/335,252, 10/335,218, 10/335,211, 10/335,257, 10/335,217, 10/335,212, and 10/335,241, 10/335,183, (Attorney Docket Nos. 38187-2633 through 38187-2652) filed December 31, 2002. This application is also a continuation-in-part of commonly assigned, copending U.S. Patent Application Ser. No. 10/425,815 (Attorney Docket No. 38187-2663) filed May 30, 2003. This application is a continuation-in-part of commonly assigned, copending U.S. Patent Application Ser. No. 10/323,622 (Attorney Docket No. 38187-2606) filed on December 18, 2002, which is a continuation-in-part of commonly assigned, copending U.S. Patent Application Ser. No. 10/127,395 (Attorney Docket No. 38187-2551)jfiled April 19, 2002. This application is also a continuation-in-part of commonly assigned, copending U.S. Patent Application Ser. No. 10/237,261 (Attorney Docket No. 38187-2595) filed September 5, 2002. This application is further a continuation-in-part of commonly assigned, copending U.S. Patent Application Ser. No. 10/420,535 (Attorney Docket No. 38187-2664) filed April 21, 2003. This application is further a continuation-in-part of commonly assigned, copending U.S. Patent Application Ser. No. 10/335,142 (Attorney, Docket No. 38187-2633) filed December 31, 2002. This application is further a continuation-in-part of commonly assigned, copending U.S. Patent Application Ser. No. 10/423,851 (Attorney Docket No. 38187-2657) filed April 24, 2003. This application also claims the benefit of priority from commonly assigned, copending U.S. Provisional Patent Application Ser. No. 60/422,988 (Attorney Docket No. 38187-2601) filed November 1, 2002; commonly assigned, copending U.S. Provisional Patent Application Ser. No. 60/424,429 (Attorney Docket No. 38187-2602) filed November 6, 2002; and commonly assigned, copending U.S. Provisional Patent Application Ser. No. 60/424,429 (Attorney Docket No. 38187-2604) filed November 20, 2002. All applications listed above are incorporated herein by reference for all purposes. Additionally, U.S. Applications Ser. Nos. 60/478,041, 60/478,692, 60/478,662, and 60/483,324 are fully incorporated herein by reference for all purposes. The publications discussed or cited herein are provided solely for their disclosure prior to the filing date ofthe present application. Nothing herein is to be construed as an admission that the present invention is not entitled to antedate such publication by virtue of prior invention. Further, the dates of publication provided may be different from the actual publication dates which may need to be independently confirmed. All publications mentioned herein are incoφorated herein by reference to disclose and describe the structures and/or methods in connection with which the publications are cited. Expected variations or differences in the results are contemplated in accordance with the objects and practices ofthe present invention. It is intended, therefore, that the invention be defined by the scope ofthe claims which follow and that such claims be inteφreted as broadly as is reasonable.

Claims

WHAT IS CLAIMED IS: 1. A method of controlling a penetrating member, the method comprising: f (a) providing a device comprising a penetrating member driver having a position sensor and a processor; (b) accelerating the penetrating member towards a target tissue; and (c) using a control algorithm to control the driver to move the penetrating member to follow a desired velocity trajectory.
2. A method of body fluid sampling comprising: [2687] moving a penetrating member at conforming to a selectable velocity profile or motion waveform; using a pie-shaped cartridge for housing said penetrating member; piercing a storage area having a sensing area; piercing another storage area having an enzyme area separate from the sensing area prior to piercing; causing fluid to first flow to the enzyme area and then to the sensing area.
3. The device of claim 1 further comprising storing said enzyme area in an inert environment different from an environment for the sensing area.
4. A device for body fluid sampling usable with a cartridge housing a plurality of penetrating members, the device comprising: a housing; ι a penetrating member driver coupled to said housing and for use with said cartridge; a processor for controlling said penetrating member driver to move at least one of said penetrating members at velocities which conform with a selectable velocity profile; a storage area having a sensing area; another storage area having an enzyme area separate from the sensing area prior to piercing; wherein said penetrating member pierces opens both storage areas upon member actuation and causing body fluid to first flow to the enzyme area and then to the sensing area.
5. A method of body fluid sampling comprising: [2599] moving a penetrating member at conforming to a selectable velocity profile or motion waveform; achieving higher rates of spontaneous blood and higher spontaneous yields by controlling depth of penetration.
6. The device of claim 1 wherem the penetrating member trajectory waveform contains a stationary portion.
7. A device for body fluid sampling usable with a cartridge housing a plurality of penetrating members, the device comprising: a housing; a penetrating member driver coupled to said housing and for use with said cartridge; a processor for controlling said penetrating member driver to move at least one of said penetrating members at velocities which conform with a selectable velocity profile.
8. The device of claim 3 comprising a window allowing a user to see the cartridge while the cartridge is in said housing.
9. The device of claim 3 comprising display showing device status.
10. The device of claim 3 comprising display showing lancing performance.
11. The device of claim 3 comprising display showing lancing parameters.
12. The device of claim 3 comprising a single button for actuating said penetrating member driver along an inbound path into tissue and then an outbound path out ofthe tissue. I I
13. The device of claim 3 wherein said penetrating member driver moves an active one of said penetrating members along a velocity profile that reduces initial pain and residual pain to levels below that of known devices.
14. The device of claim 3 wherein said, penetrating member driver moves an active one of said penetrating members along a velocity profile that reduces initial pain and residual pain to levels at least 1.5 times less than that of known devices.
15. The device of claim 3 wherein said penetrating member driver moves an active one of said penetrating members along a velocity profile that reduces residual pain to levels at least 2 times less than that of jαiown devices.
16. A body fluid sampling device for use with a cartridge containing a plurality of penetrating members comprising: [2685] ^ a penetrating member driver for moving an active one of said penetrating members from a first position outward to penetrate tissue; a penetrating member coupler attached to said driver; } a cutting device that simultaneously cuts a sterility barrier on said cartridge while moving along a path that rotates the cartridge about its center to align the newly opened cavity in the cartridge with the penetrating member coupler.
17. The device of claim 1 wherein the penetrating member driver is coupled to a position sensor, said sensor used to detect a position ofthe active one of said penetrating member.
18. A body fluid sampling device for use with a cartridge containing a plurality of penetrating members comprising: a penetrating member driver for moving an active one of said penetrating members from a first position outward to penetrate tissue; a penetrating member coupler attached to said driver; a cutting device that simultaneously cuts a sterility barrier on said cartridge while moving along a path that rotates the cartridge about its center to align the newly opened cavity in the cartridge with the penetrating member coupler; a display coupled to the driver for showing the number of lancets remaining.
19. A body fluid sampling device for use with a cartridge containing a plurality of penetrating members comprising: [2686] a penetrating member driver for moving an active one of said penetrating members from a first position outward to penetrate tissue; a housing coupled to said driver; a display on said housing showing a number of unused penetrating members remaining.
20. The device of claim 1 wherein the penetrating member driver is coupled to a position sensor, said sensor used to detect a position ofthe active one of said penetrating member.
21. A body fluid sampling device for use with a cartridge containing a plurality of penetrating members comprising: a penetrating member driver for moving an active one of said penetrating members from a first position outward to penetrate tissue; a housing having a rectangular configuration.
22. A body fluid sampling device for use with a cartridge containing a plurality of penetrating members comprising: a penetrating member driver for moving an active one of said penetrating members from a first position outward to penetrate tissue; a housing having a golden color; a position sensor, said sensor used to detect a position ofthe active one of said penetrating member.
23. A body fluid sampling device for use with a cartridge containing a plurality of penetrating members comprising: a penetrating member driver for moving an active one of said penetrating members from a first position outward to penetrate tissue; a cavity to house the cartridge containing said penetrating members, said cartridge being a circular disc having a fracturable sterility seal covering a top opening' , and a side opening.
24. A body fluid sampling device for use with a'cartridge 'containing a plurality of penetrating members comprising: a penetrating member driver for moving an active one of said penetrating members from a first position outward to penetrate tissue; electronic setting of lancing parameters used by said penetrating member driver.
25. A body fluid sampling device for use with a cartridge containing a plurality of penetrating members comprising: a penetrating member driver for moving an active one of said penetrating members from a first position outward to penetrate tissue; settings for lancing parameters used by said penetrating member driver remain in memory without battery.
26. A body fluid sampling device for use with a cartridge containing a plurality of penetrating members comprising: a penetrating member driver for moving an active one[ of said penetrating members from a first position outward to penetrate tissue; a processor having a safety feature such that the penetrating member driver only lances material with properties similar to skin.
27. A body fluid sampling device for use with a cartridge containing a plurality of penetrating members comprising: a penetrating member driver for moving an active one of said penetrating members from a first position outward to penetrate tissue; a processor having a safety feature such that the penetrating member driver does not fire the active penetrating member in to air or materials harder than flesh.
28. A body fluid sampling device for use with a cartridge containing a plurality of penetrating members comprising: a penetrating member driver for moving an active one of said penetrating members from a first position outward to penetrate tissue; a processor having a safety feature such that the penetrating member driver wherein a hard detect or an impact against material harder than tissue invalidates usage of the penetrating member.
29. A body fluid sampling device for use with a cartridge containing a plurality of penetrating members comprising: a penetrating member driver for moving an active one of said penetrating members from a first position outward to penetrate tissue; a display showing penetrating members left/penetrating members spent.
30. A body fluid sampling device for use with a cartridge containing a plurality of penetrating members comprising: a penetrating member driver for moving an active one of said penetrating members from a first position outward to penetrate tissue; depth setting of penetrating member penetration into tissue independent of front end geometry.
31. A body fluid sampling device for use with a cartridge containing a plurality of penetrating members comprising: a penetrating member driver for moving an active one of said penetrating members from a first position outward to penetrate tissue; a processor programmed to track position and energy used by the driver to sense position or proximity of skin.
32. A body fluid sampling device for use with a cartridge containing a plurality of penetrating members comprising: a penetrating member driver for moving an active one of said penetrating members from a first position outward to penetrate tissue; a display that has a screen saver.
33. A body fluid sampling device for use with a cartridge containing a plurality of penetrating members comprising: a penetrating member driver for moving an active one of said penetrating members from a first position outward to penetrate tissue; a display that relays a "too deep" signal to a user based on the lancing event.
34. A fluid sampling device comprising: I ' " ι a housing; a cartridge defining a plurality of cavities said cartridge sized to fit within said housing; and ' ' a plurality of penetrating members at least partially contained in said cavities ofthe cartridge wherein the penetrating members are slidably movable to extend outward from said cartridge to penetrate tissue, said cavities each having a longitudinal opening providing access to an elongate portion ofthe penetrating member; a sterility barrier coupled to said cartridge, said sterility barrier covering a plurality ofthe longitudinal openings, wherein the sterility barrier covering the lateral openings is configured to be moved so that the elongate portion may be accessed by the gripper without touching the barrier; and a slider located on a surface of said housing, said slider movable in a linear direction to rotate said cartridge to bring an unused penetrating member into position for use; a tooth gear coupled to said slider to control a distance said slider can travel; a follower coupled to said slider; a cam surface engaged by said follower to lift said cartridge a desired I' distance above a first position to allow for rotation ofthe cartridge without engaging a gripper used to advance the penetrating member.
35. The device of claim 1 wherein said cam surface is aligned parallel to said slider.
36. The device of claim 1 wherein said linear motion ofthe cam rotates the cartridge and moves a plunger to break the sterility barrier on the cartridge.
37. The device of claim 1 wherein cam surface comprise a linear strip of material with at least two raised portions and two depressed portions.
38. A device for use in penetrating tissue to obtain a body fluid sample, comprising: a cartridge; and a plurality of penetrating members slidably coupled to the cartridge, each of said penetrating members having a distal end sufficiently shaφ to pierce tissue and each of said penetrating members being moveable relative to the other ones ofthe penetrating members, so that the distal end ofthe respective penetrating member is movable to penetrate tissue; wherein each of said penetrating member is a bare lancet does not penetrate an outer sterility barrier during actuation.
39. A device comprising: a cartridge having a plurality of cavities; and a plurality of penetrating members at least partially contained in said cavities ofthe single cartridge wherein the penetrating members are slidably movable to extend outward from lateral openings on said cartridge to penetrate tissue; a sterility barrier coupled to said cartridge, said sterility barrier covering a plurality of said lateral openings, wherein the sterility barrier covering the lateral openings is configured to be moved so that a penetrating member exits the lateral opening without contacting the barrier.
40. The device of claim 39 wherein the sterility barrier covering the lateral openings is configured to be moved substantially vertically so that a penetrating member exits the lateral opening without contacting the barrier.
41. A device comprising: a housing; a penetrating member driver; a cartridge containing a plurality of penetrating members; a display on said cartridge; a linear slider on the housing, said slider coupled to a rod; said rod moving with said slider, said rod having at least one roller using the linear motion ofthe slider to rotate the cartridge, punch open a new cavity and load a new penetrating member.
42. A method of indexing comprising: moving a linear slider; said linear slider coupled to a rod; said rod moving with said slider, said rod having at least one roller using the linear motj-on ofthe slider and linear motion ofthe rod to push at least one linear slider and to roll a roller along a linear cam surfaces to lift clear a drive assembly, rotate the cartridge, punch open a new cavity and load a ^ew penetrating member.
PCT/US2004/019125 2003-06-11 2004-06-14 Method and apparatus for body fluid sampling and analyte sensing WO2005006939A2 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
US47804103P true 2003-06-11 2003-06-11
US60/478,041 2003-06-11
US47866203P true 2003-06-13 2003-06-13
US47869203P true 2003-06-13 2003-06-13
US60/478,692 2003-06-13
US60/478,662 2003-06-13
US48332403P true 2003-06-27 2003-06-27
US60/483,324 2003-06-27

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04776622A EP1635702A4 (en) 2003-06-11 2004-06-14 Method and apparatus for body fluid sampling and analyte sensing
US10/560,263 US20060241666A1 (en) 2003-06-11 2004-06-14 Method and apparatus for body fluid sampling and analyte sensing

Publications (2)

Publication Number Publication Date
WO2005006939A2 true WO2005006939A2 (en) 2005-01-27
WO2005006939A3 WO2005006939A3 (en) 2005-03-31

Family

ID=34084725

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/019125 WO2005006939A2 (en) 2003-06-11 2004-06-14 Method and apparatus for body fluid sampling and analyte sensing

Country Status (3)

Country Link
US (1) US20060241666A1 (en)
EP (1) EP1635702A4 (en)
WO (1) WO2005006939A2 (en)

Cited By (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008027319A3 (en) * 2006-08-28 2008-05-02 Intuity Medical Inc Body fluid monitoring and sampling devices and methods
US7645241B2 (en) 2004-09-09 2010-01-12 Roche Diagnostics Operations, Inc. Device for sampling bodily fluids
US8152741B2 (en) 2007-10-15 2012-04-10 Roche Diagnostics Operations, Inc. Lancet wheel
US8327703B2 (en) 2008-07-17 2012-12-11 Seiko Epson Corporation Angular velocity detection circuit and angular velocity detection apparatus
US8360993B2 (en) 2005-09-30 2013-01-29 Intuity Medical, Inc. Method for body fluid sample extraction
US8677822B2 (en) 2008-07-17 2014-03-25 Seiko Epson Corporation Angular velocity detection circuit, angular velocity detection apparatus, and failure determination system
US8801631B2 (en) 2005-09-30 2014-08-12 Intuity Medical, Inc. Devices and methods for facilitating fluid transport
US8852123B2 (en) 2010-12-30 2014-10-07 Roche Diagnostics Operations, Inc. Handheld medical diagnostic devices housing with sample transfer
US8919605B2 (en) 2009-11-30 2014-12-30 Intuity Medical, Inc. Calibration material delivery devices and methods
US8961431B2 (en) 2009-09-28 2015-02-24 Roche Diagnostics Operations, Inc. Body fluid lancing, acquiring, and testing cartridge design
US8969097B2 (en) 2005-06-13 2015-03-03 Intuity Medical, Inc. Analyte detection devices and methods with hematocrit-volume correction and feedback control
US9034639B2 (en) 2002-12-30 2015-05-19 Sanofi-Aventis Deutschland Gmbh Method and apparatus using optical techniques to measure analyte levels
US9066689B2 (en) 2008-05-03 2015-06-30 Roche Diagnostics Operations, Inc. Lancet wheel and method for producing a lancet wheel
US9072842B2 (en) 2002-04-19 2015-07-07 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US9089678B2 (en) 2002-04-19 2015-07-28 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US9089294B2 (en) 2002-04-19 2015-07-28 Sanofi-Aventis Deutschland Gmbh Analyte measurement device with a single shot actuator
US9095292B2 (en) 2003-03-24 2015-08-04 Intuity Medical, Inc. Analyte concentration detection devices and methods
US9186097B2 (en) 2007-09-17 2015-11-17 Roche Diabetes Care, Inc. Body fluid lancing, acquiring, and testing cartridge design
US9248267B2 (en) 2002-04-19 2016-02-02 Sanofi-Aventis Deustchland Gmbh Tissue penetration device
US9261476B2 (en) 2004-05-20 2016-02-16 Sanofi Sa Printable hydrogel for biosensors
US9427532B2 (en) 2001-06-12 2016-08-30 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US9486164B2 (en) 2010-12-30 2016-11-08 Roche Diabetes Care, Inc. Handheld medical diagnostic device with lancet and sample transfer
US9561000B2 (en) 2003-12-31 2017-02-07 Sanofi-Aventis Deutschland Gmbh Method and apparatus for improving fluidic flow and sample capture
US9560993B2 (en) 2001-11-21 2017-02-07 Sanofi-Aventis Deutschland Gmbh Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means
US9636051B2 (en) 2008-06-06 2017-05-02 Intuity Medical, Inc. Detection meter and mode of operation
US9694144B2 (en) 2001-06-12 2017-07-04 Sanofi-Aventis Deutschland Gmbh Sampling module device and method
US9717452B2 (en) 2010-12-30 2017-08-01 Roche Diabetes Care, Inc. Handheld medical diagnostic devices with lancing speed control
US9724021B2 (en) 2002-04-19 2017-08-08 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US9782114B2 (en) 2011-08-03 2017-10-10 Intuity Medical, Inc. Devices and methods for body fluid sampling and analysis
US9795747B2 (en) 2010-06-02 2017-10-24 Sanofi-Aventis Deutschland Gmbh Methods and apparatus for lancet actuation
US9820684B2 (en) 2004-06-03 2017-11-21 Sanofi-Aventis Deutschland Gmbh Method and apparatus for a fluid sampling device
US9833183B2 (en) 2008-05-30 2017-12-05 Intuity Medical, Inc. Body fluid sampling device—sampling site interface
US9839386B2 (en) 2002-04-19 2017-12-12 Sanofi-Aventis Deustschland Gmbh Body fluid sampling device with capacitive sensor
US10034628B2 (en) 2003-06-11 2018-07-31 Sanofi-Aventis Deutschland Gmbh Low pain penetrating member

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6036924A (en) 1997-12-04 2000-03-14 Hewlett-Packard Company Cassette of lancet cartridges for sampling blood
US6391005B1 (en) 1998-03-30 2002-05-21 Agilent Technologies, Inc. Apparatus and method for penetration with shaft having a sensor for sensing penetration depth
US7892183B2 (en) 2002-04-19 2011-02-22 Pelikan Technologies, Inc. Method and apparatus for body fluid sampling and analyte sensing
US8221334B2 (en) 2002-04-19 2012-07-17 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7699791B2 (en) 2001-06-12 2010-04-20 Pelikan Technologies, Inc. Method and apparatus for improving success rate of blood yield from a fingerstick
US7976476B2 (en) 2002-04-19 2011-07-12 Pelikan Technologies, Inc. Device and method for variable speed lancet
US7674232B2 (en) 2002-04-19 2010-03-09 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7331931B2 (en) 2002-04-19 2008-02-19 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7901362B2 (en) 2002-04-19 2011-03-08 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US9314194B2 (en) 2002-04-19 2016-04-19 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US7682318B2 (en) 2001-06-12 2010-03-23 Pelikan Technologies, Inc. Blood sampling apparatus and method
US7491178B2 (en) 2002-04-19 2009-02-17 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7297122B2 (en) 2002-04-19 2007-11-20 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8267870B2 (en) 2002-04-19 2012-09-18 Sanofi-Aventis Deutschland Gmbh Method and apparatus for body fluid sampling with hybrid actuation
US7229458B2 (en) 2002-04-19 2007-06-12 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7717863B2 (en) 2002-04-19 2010-05-18 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7648468B2 (en) 2002-04-19 2010-01-19 Pelikon Technologies, Inc. Method and apparatus for penetrating tissue
EP1404233B1 (en) 2001-06-12 2009-12-02 Pelikan Technologies Inc. Self optimizing lancing device with adaptation means to temporal variations in cutaneous properties
US7371247B2 (en) 2002-04-19 2008-05-13 Pelikan Technologies, Inc Method and apparatus for penetrating tissue
US7909778B2 (en) 2002-04-19 2011-03-22 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8337419B2 (en) 2002-04-19 2012-12-25 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US7344507B2 (en) 2002-04-19 2008-03-18 Pelikan Technologies, Inc. Method and apparatus for lancet actuation
WO2002100254A2 (en) 2001-06-12 2002-12-19 Pelikan Technologies, Inc. Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge
US7232451B2 (en) 2002-04-19 2007-06-19 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US9226699B2 (en) 2002-04-19 2016-01-05 Sanofi-Aventis Deutschland Gmbh Body fluid sampling module with a continuous compression tissue interface surface
US7547287B2 (en) 2002-04-19 2009-06-16 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7981056B2 (en) 2002-04-19 2011-07-19 Pelikan Technologies, Inc. Methods and apparatus for lancet actuation
WO2002100460A2 (en) 2001-06-12 2002-12-19 Pelikan Technologies, Inc. Electric lancet actuator
US7291117B2 (en) 2002-04-19 2007-11-06 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US20120296233A9 (en) * 2002-09-05 2012-11-22 Freeman Dominique M Methods and apparatus for an analyte detecting device
US7850621B2 (en) 2003-06-06 2010-12-14 Pelikan Technologies, Inc. Method and apparatus for body fluid sampling and analyte sensing
WO2005033659A2 (en) 2003-09-29 2005-04-14 Pelikan Technologies, Inc. Method and apparatus for an improved sample capture device
WO2005037095A1 (en) 2003-10-14 2005-04-28 Pelikan Technologies, Inc. Method and apparatus for a variable user interface
WO2006072004A2 (en) * 2004-12-30 2006-07-06 Pelikan Technologies, Inc. Method and apparatus for analyte measurement test time
US8652831B2 (en) 2004-12-30 2014-02-18 Sanofi-Aventis Deutschland Gmbh Method and apparatus for analyte measurement test time
US20080214917A1 (en) * 2004-12-30 2008-09-04 Dirk Boecker Method and apparatus for analyte measurement test time
US7822454B1 (en) 2005-01-03 2010-10-26 Pelikan Technologies, Inc. Fluid sampling device with improved analyte detecting member configuration
WO2006102348A1 (en) * 2005-03-22 2006-09-28 Bayer Healthcare Llc Packaging container for test sensors
EP1877778A1 (en) * 2005-03-22 2008-01-16 Bayer HealthCare LLC Packaging container for test sensors
US8162968B2 (en) * 2006-04-10 2012-04-24 Agamatrix, Inc. Lancing device
EP1880671B1 (en) * 2006-07-18 2010-09-08 Roche Diagnostics GmbH Lancet wheel
CA2675275C (en) * 2007-01-12 2013-06-25 Facet Technologies, Llc Multi-lancet cartridge and lancing device
WO2009075907A2 (en) * 2007-07-05 2009-06-18 Facet Technologies, Llc Multi-lancet cartridge and lancing device
WO2008111937A1 (en) 2007-03-12 2008-09-18 Bayer Healthcare Llc Analyte-testing instruments
WO2009126900A1 (en) 2008-04-11 2009-10-15 Pelikan Technologies, Inc. Method and apparatus for analyte detecting device
US9375169B2 (en) 2009-01-30 2016-06-28 Sanofi-Aventis Deutschland Gmbh Cam drive for managing disposable penetrating member actions with a single motor and motor and control system
US20100198107A1 (en) * 2009-01-30 2010-08-05 Roche Diagnostics Operations, Inc. Integrated blood glucose meter and lancing device
US9517027B2 (en) * 2009-07-10 2016-12-13 Facet Techonologies, Llc Advancement mechanism for cartridge-based devices
CA2775775C (en) * 2009-10-02 2018-11-13 The Regents Of The University Of Michigan Multimodal automated sensory testing system
US8965476B2 (en) 2010-04-16 2015-02-24 Sanofi-Aventis Deutschland Gmbh Tissue penetration device

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030083685A1 (en) 2001-06-12 2003-05-01 Freeman Dominique M. Sampling module device and method

Family Cites Families (101)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3712293A (en) * 1970-07-27 1973-01-23 Mielke C Apparatus and method for measuring hemostatic properties of platelets
US3712292A (en) * 1971-07-20 1973-01-23 Karen Lafley V Method and apparatus for producing swept frequency-modulated audio signal patterns for inducing sleep
US4184486A (en) * 1977-08-11 1980-01-22 Radelkis Elektrokemiai Muszergyarto Szovetkezet Diagnostic method and sensor device for detecting lesions in body tissues
SE422150B (en) * 1980-04-23 1982-02-22 Enstroem Hans Device for piercing the skin and seen to be stella such a device
US4425039A (en) * 1982-05-07 1984-01-10 Industrial Holographics, Inc. Apparatus for the practice of double exposure interferometric non-destructive testing
GB8316824D0 (en) * 1983-06-21 1983-07-27 Microsurgical Equipment Ltd Device for member to penetrate workpiece
US5279294A (en) * 1985-04-08 1994-01-18 Cascade Medical, Inc. Medical diagnostic system
US4627445A (en) * 1985-04-08 1986-12-09 Garid, Inc. Glucose medical monitoring system
US4712460A (en) * 1985-11-18 1987-12-15 Biotrack, Inc. Integrated drug dosage form and metering system
US4895156A (en) * 1986-07-02 1990-01-23 Schulze John E Sensor system using fluorometric decay measurements
US4935346A (en) * 1986-08-13 1990-06-19 Lifescan, Inc. Minimum procedure system for the determination of analytes
US5070886A (en) * 1988-01-22 1991-12-10 Safety Diagnostice, Inc. Blood collection and testing means
AT393565B (en) * 1988-08-09 1991-11-11 Avl Verbrennungskraft Messtech Disposable measuring element
US5181914A (en) * 1988-08-22 1993-01-26 Zook Gerald P Medicating device for nails and adjacent tissue
US5178142A (en) * 1989-05-23 1993-01-12 Vivascan Corporation Electromagnetic method and apparatus to measure constituents of human or animal tissue
US4984085A (en) * 1989-08-03 1991-01-08 Allen-Bradley Company, Inc. Image processor with dark current compensation
US6395227B1 (en) * 1989-08-28 2002-05-28 Lifescan, Inc. Test strip for measuring analyte concentration over a broad range of sample volume
US5181910A (en) * 1991-02-28 1993-01-26 Pharmacia Deltec, Inc. Method and apparatus for a fluid infusion system with linearized flow rate change
US5593852A (en) * 1993-12-02 1997-01-14 Heller; Adam Subcutaneous glucose electrode
CA2062027C (en) * 1991-03-04 1998-05-19 William Aldrich Liquid control system for diagnostic cartridges used in analytical instruments
US6991918B2 (en) * 1991-04-18 2006-01-31 Becton Dickinson And Co., Methods for improving sensitivity of oxygen biosensors
US5277181A (en) * 1991-12-12 1994-01-11 Vivascan Corporation Noninvasive measurement of hematocrit and hemoglobin content by differential optical analysis
US6168563B1 (en) * 1992-11-17 2001-01-02 Health Hero Network, Inc. Remote health monitoring and maintenance system
US20040019259A1 (en) * 1992-11-17 2004-01-29 Brown Stephen J. Remote monitoring and data management platform
EP0622626B1 (en) * 1993-04-23 2002-03-06 Boehringer Mannheim Gmbh System for analysing the components of fluid samples
US6334778B1 (en) * 1994-04-26 2002-01-01 Health Hero Network, Inc. Remote psychological diagnosis and monitoring system
US5591139A (en) * 1994-06-06 1997-01-07 The Regents Of The University Of California IC-processed microneedles
US6335203B1 (en) * 1994-09-08 2002-01-01 Lifescan, Inc. Optically readable strip for analyte detection having on-strip orientation index
US5585069A (en) * 1994-11-10 1996-12-17 David Sarnoff Research Center, Inc. Partitioned microelectronic and fluidic device array for clinical diagnostics and chemical synthesis
US6018289A (en) * 1995-06-15 2000-01-25 Sekura; Ronald D. Prescription compliance device and method of using device
KR0135178Y1 (en) * 1995-06-26 1999-03-20 김인환 Lancet device for obtaining blood samples
US5856174A (en) * 1995-06-29 1999-01-05 Affymetrix, Inc. Integrated nucleic acid diagnostic device
US5709699A (en) * 1995-09-01 1998-01-20 Biosafe Diagnostics Corporation Blood collection and testing device
ES2236759T3 (en) * 1995-12-19 2005-07-16 Abbott Laboratories Detection device and an analytical administering a therapeutic substance.
EP1579814A3 (en) * 1996-05-17 2006-06-14 Roche Diagnostics Operations, Inc. Methods and apparatus for sampling and analyzing body fluid
US6015392A (en) * 1996-05-17 2000-01-18 Mercury Diagnostics, Inc. Apparatus for sampling body fluid
US5856195A (en) * 1996-10-30 1999-01-05 Bayer Corporation Method and apparatus for calibrating a sensor element
US5855377A (en) * 1996-11-13 1999-01-05 Murphy; William G. Dead length collect chuck assembly
US6177931B1 (en) * 1996-12-19 2001-01-23 Index Systems, Inc. Systems and methods for displaying and recording control interface with television programs, video, advertising information and program scheduling information
US6991940B2 (en) * 1997-06-10 2006-01-31 Home Diagnostics, Inc. Diagnostic sanitary test strip
US6168957B1 (en) * 1997-06-25 2001-01-02 Lifescan, Inc. Diagnostic test strip having on-strip calibration
US5857967A (en) * 1997-07-09 1999-01-12 Hewlett-Packard Company Universally accessible healthcare devices with on the fly generation of HTML files
US6982431B2 (en) * 1998-08-31 2006-01-03 Molecular Devices Corporation Sample analysis systems
US6071391A (en) * 1997-09-12 2000-06-06 Nok Corporation Enzyme electrode structure
US5971941A (en) * 1997-12-04 1999-10-26 Hewlett-Packard Company Integrated system and method for sampling blood and analysis
US6036924A (en) * 1997-12-04 2000-03-14 Hewlett-Packard Company Cassette of lancet cartridges for sampling blood
IES81031B2 (en) * 1998-03-25 1999-10-20 Trinity College Dublin A device for acquiring body samples for analysis
US6139562A (en) * 1998-03-30 2000-10-31 Agilent Technologies, Inc. Apparatus and method for incising
US6175752B1 (en) * 1998-04-30 2001-01-16 Therasense, Inc. Analyte monitoring device and methods of use
US6990365B1 (en) * 1998-07-04 2006-01-24 Edwards Lifesciences Apparatus for measurement of blood analytes
US6540672B1 (en) * 1998-12-09 2003-04-01 Novo Nordisk A/S Medical system and a method of controlling the system for use by a patient for medical self treatment
FR2790635B1 (en) * 1999-03-05 2001-04-13 France Etat triboelectric device
US6336900B1 (en) * 1999-04-12 2002-01-08 Agilent Technologies, Inc. Home hub for reporting patient health parameters
US6176847B1 (en) * 1999-05-14 2001-01-23 Circon Corporation Surgical irrigation system incorporating flow sensor device
DE19945828B4 (en) * 1999-09-24 2011-06-01 Roche Diagnostics Gmbh Analytical element and method for determining an analyte in liquid
JP4210782B2 (en) * 1999-10-13 2009-01-21 アークレイ株式会社 Blood collection position display device
US6558320B1 (en) * 2000-01-20 2003-05-06 Medtronic Minimed, Inc. Handheld personal data assistant (PDA) with a medical device and method of using the same
US6485923B1 (en) * 2000-02-02 2002-11-26 Lifescan, Inc. Reagent test strip for analyte determination having hemolyzing agent
US6612111B1 (en) * 2000-03-27 2003-09-02 Lifescan, Inc. Method and device for sampling and analyzing interstitial fluid and whole blood samples
US6540675B2 (en) * 2000-06-27 2003-04-01 Rosedale Medical, Inc. Analyte monitor
US6561989B2 (en) * 2000-07-10 2003-05-13 Bayer Healthcare, Llc Thin lance and test sensor having same
US6982027B2 (en) * 2000-10-27 2006-01-03 Arkray, Inc. Biosensor
US6512986B1 (en) * 2000-12-30 2003-01-28 Lifescan, Inc. Method for automated exception-based quality control compliance for point-of-care devices
CN101849829A (en) * 2001-01-12 2010-10-06 爱科来株式会社 Punctur device
US6983176B2 (en) * 2001-04-11 2006-01-03 Rio Grande Medical Technologies, Inc. Optically similar reference samples and related methods for multivariate calibration models used in optical spectroscopy
US6988996B2 (en) * 2001-06-08 2006-01-24 Roche Diagnostics Operatons, Inc. Test media cassette for bodily fluid testing device
US6721586B2 (en) * 2001-06-12 2004-04-13 Lifescan, Inc. Percutaneous biological fluid sampling and analyte measurement devices and methods
US6796963B2 (en) * 2001-07-10 2004-09-28 Myocardial Therapeutics, Inc. Flexible tissue injection catheters with controlled depth penetration
US6843902B1 (en) * 2001-07-20 2005-01-18 The Regents Of The University Of California Methods for fabricating metal nanowires
US6984307B2 (en) * 2001-10-05 2006-01-10 Stephen Eliot Zweig Dual glucose-hydroxybutyrate analytical sensors
EP1439777A1 (en) * 2001-10-26 2004-07-28 Disetronic Licensing AG Simulation device for playful evaluation and display of blood sugar levels
US6989891B2 (en) * 2001-11-08 2006-01-24 Optiscan Biomedical Corporation Device and method for in vitro determination of analyte concentrations within body fluids
US6689411B2 (en) * 2001-11-28 2004-02-10 Lifescan, Inc. Solution striping system
US6503290B1 (en) * 2002-03-01 2003-01-07 Praxair S.T. Technology, Inc. Corrosion resistant powder and coating
US6682933B2 (en) * 2002-03-14 2004-01-27 Lifescan, Inc. Test strip qualification system
US6673617B2 (en) * 2002-03-14 2004-01-06 Lifescan, Inc. Test strip qualification system
USD484980S1 (en) * 2002-03-18 2004-01-06 Braun Gmbh Blood pressure measuring device
US6986777B2 (en) * 2002-04-22 2006-01-17 Yong Pil Kim Automatic lancing device
GB2388031B (en) * 2002-04-30 2005-07-27 Abbott Lab A lancet removal tool
US7452365B2 (en) * 2003-07-28 2008-11-18 Helena Laboratories Load-controlled device for a patterned skin incision of constant depth
US8326388B2 (en) * 2002-10-31 2012-12-04 Toshiba Medical Systems Corporation Method and apparatus for non-invasive measurement of living body characteristics by photoacoustics
US6983177B2 (en) * 2003-01-06 2006-01-03 Optiscan Biomedical Corporation Layered spectroscopic sample element with microporous membrane
DE10302501A1 (en) * 2003-01-23 2004-08-05 Roche Diagnostics Gmbh Apparatus and method for receiving a body fluid for analytical purposes
EP1522254A1 (en) * 2003-10-08 2005-04-13 Hitachi, Ltd. Blood sugar level measuring method and apparatus
US7577470B2 (en) * 2003-11-13 2009-08-18 Medtronic Minimed, Inc. Long term analyte sensor array
DE10361261B4 (en) * 2003-12-24 2006-02-09 Roche Diagnostics Gmbh Handheld analyzer
DE102004002874A1 (en) * 2004-01-20 2005-08-11 Roche Diagnostics Gmbh Analyzer for analyzing blood samples
US7819822B2 (en) * 2004-03-06 2010-10-26 Roche Diagnostics Operations, Inc. Body fluid sampling device
US6990849B2 (en) * 2004-03-26 2006-01-31 Lifescan, Inc. Microfluidic analytical system with position electrodes
US7156117B2 (en) * 2004-03-31 2007-01-02 Lifescan Scotland Limited Method of controlling the movement of fluid through a microfluidic circuit using an array of triggerable passive valves
US7623988B2 (en) * 2004-06-23 2009-11-24 Cybiocare Inc. Method and apparatus for the monitoring of clinical states
US20060000549A1 (en) * 2004-06-29 2006-01-05 Lang David K Method of manufacturing integrated biosensors
US20060006574A1 (en) * 2004-06-29 2006-01-12 Lang David K Apparatus for the manufacture of medical devices
EP1776035A2 (en) * 2004-07-01 2007-04-25 Vivomedical, Inc. Non-invasive glucose measurement
EP1774303A4 (en) * 2004-07-22 2009-05-06 Targetgen Inc Method and apparatus for electrochemical detection
US7727166B2 (en) * 2004-07-26 2010-06-01 Nova Biomedical Corporation Lancet, lancet assembly and lancet-sensor combination
CA2947613A1 (en) * 2005-04-04 2006-10-12 Hypermed Imaging, Inc. Hyperspectral imaging in diabetes and peripheral vascular disease
EP1726950A1 (en) * 2005-05-24 2006-11-29 F. Hoffmann-La Roche Ag Cartridge for storing test elements
EP1743577A1 (en) * 2005-06-23 2007-01-17 Roche Diagnostics GmbH Hand-held apparatus for the analysis of bodily fluids
US20070004989A1 (en) * 2005-06-29 2007-01-04 Parvinder Dhillon Device for transdermal sampling
US20070010841A1 (en) * 2005-07-05 2007-01-11 Medical Innovations Pte Ltd Lancet assembly

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030083685A1 (en) 2001-06-12 2003-05-01 Freeman Dominique M. Sampling module device and method

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP1635702A4

Cited By (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9802007B2 (en) 2001-06-12 2017-10-31 Sanofi-Aventis Deutschland Gmbh Methods and apparatus for lancet actuation
US9694144B2 (en) 2001-06-12 2017-07-04 Sanofi-Aventis Deutschland Gmbh Sampling module device and method
US9427532B2 (en) 2001-06-12 2016-08-30 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US9560993B2 (en) 2001-11-21 2017-02-07 Sanofi-Aventis Deutschland Gmbh Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means
US9498160B2 (en) 2002-04-19 2016-11-22 Sanofi-Aventis Deutschland Gmbh Method for penetrating tissue
US9186468B2 (en) 2002-04-19 2015-11-17 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US9248267B2 (en) 2002-04-19 2016-02-02 Sanofi-Aventis Deustchland Gmbh Tissue penetration device
US9089294B2 (en) 2002-04-19 2015-07-28 Sanofi-Aventis Deutschland Gmbh Analyte measurement device with a single shot actuator
US9089678B2 (en) 2002-04-19 2015-07-28 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US9839386B2 (en) 2002-04-19 2017-12-12 Sanofi-Aventis Deustschland Gmbh Body fluid sampling device with capacitive sensor
US9072842B2 (en) 2002-04-19 2015-07-07 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US9795334B2 (en) 2002-04-19 2017-10-24 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US9724021B2 (en) 2002-04-19 2017-08-08 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US9034639B2 (en) 2002-12-30 2015-05-19 Sanofi-Aventis Deutschland Gmbh Method and apparatus using optical techniques to measure analyte levels
US9095292B2 (en) 2003-03-24 2015-08-04 Intuity Medical, Inc. Analyte concentration detection devices and methods
US10034628B2 (en) 2003-06-11 2018-07-31 Sanofi-Aventis Deutschland Gmbh Low pain penetrating member
US9561000B2 (en) 2003-12-31 2017-02-07 Sanofi-Aventis Deutschland Gmbh Method and apparatus for improving fluidic flow and sample capture
US9261476B2 (en) 2004-05-20 2016-02-16 Sanofi Sa Printable hydrogel for biosensors
US9820684B2 (en) 2004-06-03 2017-11-21 Sanofi-Aventis Deutschland Gmbh Method and apparatus for a fluid sampling device
US7645241B2 (en) 2004-09-09 2010-01-12 Roche Diagnostics Operations, Inc. Device for sampling bodily fluids
US8419657B2 (en) 2004-09-09 2013-04-16 Roche Diagnostics Operations, Inc. Device for sampling bodily fluids
US10226208B2 (en) 2005-06-13 2019-03-12 Intuity Medical, Inc. Analyte detection devices and methods with hematocrit/volume correction and feedback control
US9366636B2 (en) 2005-06-13 2016-06-14 Intuity Medical, Inc. Analyte detection devices and methods with hematocrit/volume correction and feedback control
US8969097B2 (en) 2005-06-13 2015-03-03 Intuity Medical, Inc. Analyte detection devices and methods with hematocrit-volume correction and feedback control
US8360994B2 (en) 2005-09-30 2013-01-29 Intuity Medical, Inc. Arrangement for body fluid sample extraction
US8801631B2 (en) 2005-09-30 2014-08-12 Intuity Medical, Inc. Devices and methods for facilitating fluid transport
US8360993B2 (en) 2005-09-30 2013-01-29 Intuity Medical, Inc. Method for body fluid sample extraction
US8382681B2 (en) 2005-09-30 2013-02-26 Intuity Medical, Inc. Fully integrated wearable or handheld monitor
US8795201B2 (en) 2005-09-30 2014-08-05 Intuity Medical, Inc. Catalysts for body fluid sample extraction
US9380974B2 (en) 2005-09-30 2016-07-05 Intuity Medical, Inc. Multi-site body fluid sampling and analysis cartridge
US9839384B2 (en) 2005-09-30 2017-12-12 Intuity Medical, Inc. Body fluid sampling arrangements
US9060723B2 (en) 2005-09-30 2015-06-23 Intuity Medical, Inc. Body fluid sampling arrangements
WO2008027319A3 (en) * 2006-08-28 2008-05-02 Intuity Medical Inc Body fluid monitoring and sampling devices and methods
US8372015B2 (en) 2006-08-28 2013-02-12 Intuity Medical, Inc. Body fluid sampling device with pivotable catalyst member
US9186097B2 (en) 2007-09-17 2015-11-17 Roche Diabetes Care, Inc. Body fluid lancing, acquiring, and testing cartridge design
US8152741B2 (en) 2007-10-15 2012-04-10 Roche Diagnostics Operations, Inc. Lancet wheel
US9066689B2 (en) 2008-05-03 2015-06-30 Roche Diagnostics Operations, Inc. Lancet wheel and method for producing a lancet wheel
US9833183B2 (en) 2008-05-30 2017-12-05 Intuity Medical, Inc. Body fluid sampling device—sampling site interface
US9636051B2 (en) 2008-06-06 2017-05-02 Intuity Medical, Inc. Detection meter and mode of operation
US8327703B2 (en) 2008-07-17 2012-12-11 Seiko Epson Corporation Angular velocity detection circuit and angular velocity detection apparatus
US8677822B2 (en) 2008-07-17 2014-03-25 Seiko Epson Corporation Angular velocity detection circuit, angular velocity detection apparatus, and failure determination system
US8671755B2 (en) 2008-07-17 2014-03-18 Seiko Epson Corporation Angular velocity detection circuit and angular velocity detection apparatus
US8961431B2 (en) 2009-09-28 2015-02-24 Roche Diagnostics Operations, Inc. Body fluid lancing, acquiring, and testing cartridge design
US8919605B2 (en) 2009-11-30 2014-12-30 Intuity Medical, Inc. Calibration material delivery devices and methods
US9897610B2 (en) 2009-11-30 2018-02-20 Intuity Medical, Inc. Calibration material delivery devices and methods
US9795747B2 (en) 2010-06-02 2017-10-24 Sanofi-Aventis Deutschland Gmbh Methods and apparatus for lancet actuation
US8852123B2 (en) 2010-12-30 2014-10-07 Roche Diagnostics Operations, Inc. Handheld medical diagnostic devices housing with sample transfer
US9717452B2 (en) 2010-12-30 2017-08-01 Roche Diabetes Care, Inc. Handheld medical diagnostic devices with lancing speed control
US9486164B2 (en) 2010-12-30 2016-11-08 Roche Diabetes Care, Inc. Handheld medical diagnostic device with lancet and sample transfer
US9782114B2 (en) 2011-08-03 2017-10-10 Intuity Medical, Inc. Devices and methods for body fluid sampling and analysis

Also Published As

Publication number Publication date
WO2005006939A3 (en) 2005-03-31
EP1635702A2 (en) 2006-03-22
EP1635702A4 (en) 2009-01-21
US20060241666A1 (en) 2006-10-26

Similar Documents

Publication Publication Date Title
EP1404233B1 (en) Self optimizing lancing device with adaptation means to temporal variations in cutaneous properties
JP4573878B2 (en) Puncture system for body fluid collection
EP1585558B1 (en) Apparatus for lancet actuation
US6616616B2 (en) Lancet system
CA2562353C (en) Cap displacement mechanism for lancing device and multi-lancet cartridge
US7927291B2 (en) Blood acquisition suspension system
US7727167B2 (en) Lancet sensor assembly and meter
EP1706026B1 (en) Method and apparatus for improving fluidic flow and sample capture
US20060224172A1 (en) Blood sampling device
US20030212345A1 (en) Minimal procedure analyte test system
US20080269791A1 (en) Kinked lancet
US8282576B2 (en) Method and apparatus for an improved sample capture device
US20060195128A1 (en) Method and apparatus for loading penetrating members
US7749174B2 (en) Method and apparatus for lancet launching device intergrated onto a blood-sampling cartridge
KR100941898B1 (en) Lancets for bodily fluid sampling supplied on a tape
JP6194307B2 (en) Lancet operating method and apparatus
US9179872B2 (en) Lancets for bodily fluid sampling supplied on a tape
US9089294B2 (en) Analyte measurement device with a single shot actuator
ES2347248T3 (en) Method and apparatus for injecting fluid.
US9351680B2 (en) Method and apparatus for a variable user interface
JP2010505567A (en) Tape transport lancet sampler
US9839386B2 (en) Body fluid sampling device with capacitive sensor
JP4996811B2 (en) Device and manufacturing method thereof penetrating tissue
US20090259146A1 (en) Method and apparatus for analyte detecting device
EP2068701A2 (en) Integrated meter for analyzing biological samples

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2004776622

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2004776622

Country of ref document: EP

ENP Entry into the national phase in:

Ref document number: 2006241666

Country of ref document: US

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 10560263

Country of ref document: US

Ref document number: 2006241666

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 10560263

Country of ref document: US